2010 Annual Meeting | Poster Session 01

Date Tuesday 04/13/10

Time 07:30 AM - 12:00 PM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Scientific Poster Session

Topic(s) Cerebrovascular Disease and Interventional Neurology, Movement Disorders, Aging and Dementia, Anterior Horn, Child Neurology/Developmental Neurobiology, Clinical Neurophysiology, Critical Care/Emergency Neurology/Trauma, Epilepsy, MS and Related Diseases, Muscle Disease/Neuromuscular Junction, Neuroepidemiology/Health Services and Outcomes Research, Neurologic ��ɫ��

CME Available No CME available

Event Timeline
07:30 AM - 08:30 AM		Break
07:30 AM - 12:00 PM	Abstract	001 - What Is the Effect of Logging Abnormal Clinical Signs on Medical Student Knowledge Acquisition during the Neurology Clerkship?
07:30 AM - 12:00 PM	Abstract	002 - Effectiveness of a Web-Based Essential Neurologic Exam Video Tutorial in Combination with a Didactic Lecture vs. Didactic Lecture Alone: A Randomized Trial
07:30 AM - 12:00 PM	Abstract	003 - Neurology Residents as Teachers: A Medical Student Perspective
07:30 AM - 12:00 PM	Abstract	004 - Neurology Residents' Perceptions of Peer-Driven Neurology Board Review Sessions
07:30 AM - 12:00 PM	Abstract	005 - Potential Utility of Scenario Based Simulations for Teaching Neurology Residents Interpersonal/Communication Skills and System Based Practice
07:30 AM - 12:00 PM	Abstract	006 - Teaching Cranial Nerve Examination Using a Virtual Patient and the Nintendo Wiimote[reg]: Preliminary Evaluation
07:30 AM - 12:00 PM	Abstract	007 - Review of Neurology ��ɫ�� Uses of Web 2.0
07:30 AM - 12:00 PM	Abstract	008 - Survey of Skin Preparation Technique before Neuraxial Procedures
07:30 AM - 12:00 PM	Abstract	009 - Development, Implementation and Evaluation of a Training Video To Instruct Healthcare Providers on a Formal Bedside Dysphagia Assessment for Stroke Patients
07:30 AM - 12:00 PM	Abstract	010 - Evaluation of a Stroke Alert Protocol Coupled with an ��ɫ�� Program in the Emergency Department
07:30 AM - 12:00 PM	Abstract	011 - Chairmen Perspective on Current State of Vascular and Interventional Neurology
07:30 AM - 12:00 PM	Abstract	012 - Program Directors Perspective on ��ɫ�� in Interventional Neurology
07:30 AM - 12:00 PM	Abstract	013 - Conduction Jump Measure on Motor Fibres To Improve the Electrodiagnosis of the Carpal Tunnel Syndrome
07:30 AM - 12:00 PM	Abstract	014 - Peripheral Neuropathy in Wegener Granulomatosis: Clinical and Neurophysiological Features
07:30 AM - 12:00 PM	Abstract	015 - Median Nerve Ultrasonography in Carpal Tunnel Syndrome: A Blinded Case-Control Study
07:30 AM - 12:00 PM	Abstract	016 - Peripheral (PCT) and Central (CCT) Conduction Time to Quadriceps Muscle
07:30 AM - 12:00 PM	Abstract	017 - A Prospective Study on the Electrodiagnosis of Ulnar Neuropathy at the Elbow (UNE) Based on Bayesian Principles
07:30 AM - 12:00 PM	Abstract	018 - Peripheral Neuropathy Associated to Progressive Systemic Sclerosis: Clinical and Neurophysiological Features
07:30 AM - 12:00 PM	Abstract	019 - Decline in Nerve Conduction Velocity (NCV) with Age Occurs in Proximal Nerve Segments among the Healthy Elderly
07:30 AM - 12:00 PM	Abstract	020 - Pregabalin in Post-Traumatic Peripheral Neuropathic Pain: Efficient Assessment of Efficacy in a Randomised, Double-Blind, Placebo-Controlled Crossover Study
07:30 AM - 12:00 PM	Abstract	021 - The Latency of the Skin Sympathetic Reflex Is Shorter in the Palms and the Fingers Compared to the Wrist When Elicited by an Electrical Stimulus
07:30 AM - 12:00 PM	Abstract	022 - Simultaneous Recording of the H Reflexes of the Flexor Carpi Radialis and Biceps Brachii
07:30 AM - 12:00 PM	Abstract	023 - Treatment of Hospital Onset Seizures: A Comparison between Two Hospitals
07:30 AM - 12:00 PM	Abstract	024 - Safety and Efficacy of Pregabalin in Patients with Central Post-Stroke Pain
07:30 AM - 12:00 PM	Abstract	025 - Comparison of Detection Rates of Non-Convulsive Status Epilepticus and Non-Convulsive Seizure in Critically Ill Patients Using Routine EEG and Continuous EEG in a Busy County and a Private Hospital
07:30 AM - 12:00 PM	Abstract	026 - Quantitative EEG during Nocturnal Polysomnography before and after Treatment with Sodium Oxybate
07:30 AM - 12:00 PM	Abstract	027 - Source Localization of Sleep Spindles by High Resolution EEG/MEG Recordings
07:30 AM - 12:00 PM	Abstract	028 - Ocular Vestibular Evoked Myogenic Potentials in Patients with Migraine
07:30 AM - 12:00 PM	Abstract	029 - Age-Dependent Pattern of Oxygen Metabolism Response to Continuous Visual Deprivation
07:30 AM - 12:00 PM	Abstract	030 - Frequency and Yield of Repeat Audio-Visual Electroencephalography in a Comprehensive Epilepsy Center
07:30 AM - 12:00 PM	Abstract	031 - Prevalence of Seizures and Epileptiform Activity in the Acute Setting of Cerebral Hemorrhage
07:30 AM - 12:00 PM	Abstract	032 - Repetitive Transcranial Magnetic Stimulation in Children with Attention Deficit Hyperactivity Disorder
07:30 AM - 12:00 PM	Abstract	033 - Changes in Somatosensory Evoked Potentials to Fluctuations in Mean Arterial Pressure during Endoscopic Endonasal Approach to Skull Base Surgery
07:30 AM - 12:00 PM	Abstract	035 - TMS-Related Metabolic Changes in Limbic System and Default Network in Patients with Tinnitus
07:30 AM - 12:00 PM	Abstract	036 - Local Non-Synaptic Mechanisms Underlying Very Fast Oscillations in Rasmussen's Encephalitis
07:30 AM - 12:00 PM	Abstract	038 - Imaging, Interventions and Neurologic Outcomes in 8 ICU Patients with Severe Hyperammonemia
07:30 AM - 12:00 PM	Abstract	039 - Clinical, Electrophysiologic, and Pathologic Outcomes in a Large Animal Model of Limb Ischemia
07:30 AM - 12:00 PM	Abstract	040 - Treatment with Bcl-220-34 after CCI Provides Protection Against Mitochondrial and Synaptic Loss
07:30 AM - 12:00 PM	Abstract	041 - Computed Tomography Perfusion Findings To Identify Acute Ischemic Stroke Patients for Acute Thrombolysis
07:30 AM - 12:00 PM	Abstract	042 - A Malignant Case of Acute Promyelocytic Leukemia with Occlusion of Carotid Artery by Tumor Thrombus
07:30 AM - 12:00 PM	Abstract	043 - Mortality, Impairment and Disability of Patients with Acute Traumatic Spinal Cord Injury: Does Blood Alcohol Concentration Matter?
07:30 AM - 12:00 PM	Abstract	044 - Predictors of EndotracheaI Intubation in Patients Presenting with Seizure
07:30 AM - 12:00 PM	Abstract	045 - The FOUR Score Is a Predictor of Outcome in Comatose Patients after Cardiac Arrest
07:30 AM - 12:00 PM	Abstract	047 - Clinical Interest of Long Latency Somatosensory Evoked Potentials (N60) in Postanoxic Coma
07:30 AM - 12:00 PM	Abstract	048 - Neuron Specific Enolase as a Predictor in Therapeutic Hypothermia after Cardiac Arrest
07:30 AM - 12:00 PM	Abstract	050 - The Effect of Motivation on Clinical Reaction Time Assessment in College Athletes
07:30 AM - 12:00 PM	Abstract	051 - Gender and Racial Disparity in Survival after Cardiac Arrest
07:30 AM - 12:00 PM	Abstract	052 - Prognosis after Therapeutic Hypothermia in Anoxic Brain Injury Patients Based on EEG Grading Scale
07:30 AM - 12:00 PM	Abstract	053 - Transcranial Doppler with Contrast for the Diagnosis of Vascular Lesions in Adult Patients with Sickle Cell Disease
07:30 AM - 12:00 PM	Abstract	054 - Usefulness of Echocardiography in the Routine Evaluation of Patients with Ischemic Stroke/TIA
07:30 AM - 12:00 PM	Abstract	055 - Pharmacokinetics of Extended-Release Dipyridamole Following Administration through Gastrostomy Tube
07:30 AM - 12:00 PM	Abstract	056 - Risk Profile of Subjects Enrolled in the Randomized Evaluation of Recurrent Stroke Comparing PFO Closure to Established Current Standard of Care Treatment (RESPECT) Trial over the First Six Years of Enrollment
07:30 AM - 12:00 PM	Abstract	057 - A Model for Delivery of Community-Based Secondary Prevention Care for First Time Stroke Survivors
07:30 AM - 12:00 PM	Abstract	058 - Percutaneous Closure of Patent Foramen Ovale: Guidelines, Selection Criteria and Follow Up of a Clinical Cohort
07:30 AM - 12:00 PM	Abstract	059 - Endarterectomy for "Hemodynamically Insignificant" Symptomatic Carotid Stenosis
07:30 AM - 12:00 PM	Abstract	060 - Angioplasty with Stent for Radiation-Induced Extra-Cranial Stenosis
07:30 AM - 12:00 PM	Abstract	061 - Mechanism of Ischemic Stroke in Takayasu Arteritis
07:30 AM - 12:00 PM	Abstract	062 - Lack of Impact of Local and National Stroke Awareness Campaigns on TIA Referrals to a UK District General Hospital
07:30 AM - 12:00 PM	Abstract	063 - A Retrospective Cohort Study of Substance Abuse and Length of Hospital Stay in Ischemic Stroke Patients
07:30 AM - 12:00 PM	Abstract	064 - Change in Trends in the Occurrence of Young Stroke over the Last Two Decades - A Study from a Tertiary Care University Hospital, New Delhi (India)
07:30 AM - 12:00 PM	Abstract	065 - Prehospital Delay and Related Factors in Patients with Acute Ischemic Stroke or TIA: Change over Recent 4 Years in a Community Based Hospital
07:30 AM - 12:00 PM	Abstract	067 - Neurofluctuations in Patients with Subcortical Ischemic Strokes (NISS) Study
07:30 AM - 12:00 PM	Abstract	068 - Motor Function Impairment among Elderly Population with History of Stroke
07:30 AM - 12:00 PM	Abstract	069 - Cerebral Venous Sinus Thrombosis in Males: Is It Uncommon or Under-Reported?
07:30 AM - 12:00 PM	Abstract	070 - Urinary Incontinence among Elderly Stroke Survivors
07:30 AM - 12:00 PM	Abstract	071 - Racial Disparities in Health Care Costs in Stroke Patients with or without Diabetes
07:30 AM - 12:00 PM	Abstract	072 - Investigating the Relationship between Cholesterol Level with Increased Risk of ICH in Different Races
07:30 AM - 12:00 PM	Abstract	073 - Strokes in a Developing Country, Does Gender Matter?
07:30 AM - 12:00 PM	Abstract	074 - Disparities in Acute Stroke Care: Role of Race and Insurance Status
07:30 AM - 12:00 PM	Abstract	075 - Stroke Subtypes in Hawaii: Gender, Age and Ethnicity
07:30 AM - 12:00 PM	Abstract	076 - Trends in Hospital Case-Mortality Rate for Ischemic Stroke: Does Hospital Size Matter?
07:30 AM - 12:00 PM	Abstract	077 - Correlation of Ischemic Stroke and Coronary Artery Calcium Burden: A Retrospective Analysis
07:30 AM - 12:00 PM	Abstract	078 - Inverse Association of Atheromatous Aortic Arch Disease and Atrial Fibrillation in Patients with Ischemic Stroke and Transient Ischemic Attack
07:30 AM - 12:00 PM	Abstract	079 - Prevalence and Risk Factors for Stroke in Rural Communities of Middle Belt Nigeria
07:30 AM - 12:00 PM	Abstract	080 - Known Versus De Novo Atrial Fibrillation in Patients with Acute Ischemic Stroke and Transient Ischemic Attack
07:30 AM - 12:00 PM	Abstract	081 - Differences in Risk Factor Profiles between Asymptomatic Carotid Disease and Ischemic Stroke or Transient Ischemic Attack of Non-Carotid Etiology
07:30 AM - 12:00 PM	Abstract	082 - Risk Factors and Management of Ischemic Stroke in Korean Young Adults under 49 Years Old
07:30 AM - 12:00 PM	Abstract	083 - Outcomes after Spontaneous Intracerebral Hemorrhage in South Asians: The Race Factor
07:30 AM - 12:00 PM	Abstract	084 - Prevalence of Transthoracic Echocardiographic Abnormalities in Stroke
07:30 AM - 12:00 PM	Abstract	085 - Incident Epilepsy/Seizure Disorder in US Nursing Homes by Predisposing Conditions, 2003-2007
07:30 AM - 12:00 PM	Abstract	086 - A Population-Based Study of Health Related Quality-of-Life in Migraine and Epilepsy Compared to Asthma and Diabetes
07:30 AM - 12:00 PM	Abstract	087 - Admission for Status Epilepticus over Eight Years in Tennessee: Effect of Race [amp] Age
07:30 AM - 12:00 PM	Abstract	088 - Women with Epilepsy and Folic Acid Supplementation Prior to Pregnancy
07:30 AM - 12:00 PM	Abstract	089 - Epidemiological and Neurophysiological Characteristics of Epilepsy in African American Population with HIV Infection
07:30 AM - 12:00 PM	Abstract	090 - Predictors of Refractoriness in Patients with Post-Stroke Epilepsy
07:30 AM - 12:00 PM	Abstract	091 - Analysis of 621 Death Certificates Issued during 1998-2007 in Curitiba, Brazil, Mentioning Epilepsy or Epileptic Seizures
07:30 AM - 12:00 PM	Abstract	092 - Trends in Outcomes and Hospitalization Costs among Pediatric Spinal Cord Injury Patients in the United States
07:30 AM - 12:00 PM	Abstract	093 - Trends in Outcomes and Hospitalization Costs of Infantile Botulism in United States
07:30 AM - 12:00 PM	Abstract	094 - Idiopathic Inflammatory Myopathies in Childhood: Analyze of 27 Cases
07:30 AM - 12:00 PM	Abstract	095 - Healthcare Transitions for Adolescents with Chronic Life-Limiting Neurological Illnesses: Identifying Research Priorities
07:30 AM - 12:00 PM	Abstract	096 - Paroxysmal Kinesigenic Dyskinesia: The Cleveland Clinic Experience and Literature Review
07:30 AM - 12:00 PM	Abstract	097 - Prognostic Factors for Outcome of Neonatal Seizures in Term Infants
07:30 AM - 12:00 PM	Abstract	098 - Motor Stereotypies: Normal Childhood Behavior or a Disorder?
07:30 AM - 12:00 PM	Abstract	099 - The Stereotypical Behavior of Parents Whose Children Have Stereotypies
07:30 AM - 12:00 PM	Abstract	100 - Temporal Trends in Presentation Time to the Emergency Department (ED) for Pediatric Stroke Patients: A Population-Based Study
07:30 AM - 12:00 PM	Abstract	101 - Spectrum of Disorders Seen at a Pediatric Movement Disorders and Spasticity Clinic
07:30 AM - 12:00 PM	Abstract	102 - Differential Risk Factors for Amnestic MCI and Dementia
07:30 AM - 12:00 PM	Abstract	103 - Cortical and Subcortical Gray Matter Volumes and Walking Speed in Elderly Subjects: The Three-City Study
07:30 AM - 12:00 PM	Abstract	104 - Terminal Decline in Specific Cognitive Domains in Dementia-Free Elderly, Using Change Point Analysis
07:30 AM - 12:00 PM	Abstract	105 - Interaction of High Homocysteine Level and MTHFR Polymorphism on Dementia Risk. The 3C-Dijon Study
07:30 AM - 12:00 PM	Abstract	106 - Gender Differences in the Risk Profile and Male Predominance of Silent Brain Infarction in Japanese Elderly Subjects: The Sefuri Brain MRI Study
07:30 AM - 12:00 PM	Abstract	107 - Apathy in the Very Old and the Incidence of Dementia: The Monzino 80-Plus Population-Based Study
07:30 AM - 12:00 PM	Abstract	108 - Association of Clinical Dementia Rating (CDR) and Episodic Memory (EM) Measures to Medial Temporal Atrophy (MTA) Scores among Different Ethnic Groups
07:30 AM - 12:00 PM	Abstract	109 - Cognitive Impairment Is a Major Risk Factor for the Incidence of Disability in the Oldest-Old
07:30 AM - 12:00 PM	Abstract	110 - Clinical Trials of Alzheimer's Drugs in Patients with Mild Cognitive Impairment: Enrichment of True Alzheimer's Cases through Disease Markers
07:30 AM - 12:00 PM	Abstract	111 - Macro- and Micro-Structural Brain Imaging Characteristics of Adults Who Have Maintained Cognitive Function Very Late in Life
07:30 AM - 12:00 PM	Abstract	112 - JCAHO Primary Stroke Center Core Measures: Influence of Concurrent Data Collection
07:30 AM - 12:00 PM	Abstract	113 - Impact of In-Patient Stroke Rehabilitation Units on Length of Hospital Stay: A Statewide Study
07:30 AM - 12:00 PM	Abstract	114 - Distribution of Certified Stroke Centers in the United States
07:30 AM - 12:00 PM	Abstract	115 - Endovascular and Neurosurgical Treatment of Cerebral Aneurysms among Octogenarians: Nationwide Inpatient Sample 2002-2006
07:30 AM - 12:00 PM	Abstract	116 - Level of Evidence in Current American Stroke Association Guidelines
07:30 AM - 12:00 PM	Abstract	117 - Endpoint for Clinical Trials Involving Patients with Intracerebral Hemorrhage: Modified Rankin Scale as a Dichotomized or Ordinal Outcome
07:30 AM - 12:00 PM	Abstract	118 - Transcranial Doppler Ultrasound for Detecting Intracranial Stenosis in Elderly Population. Results from the Ultrasound Screening in Adults for Intracranial Disease (USAID) Study
07:30 AM - 12:00 PM	Abstract	119 - Anxiety Disorder among Stroke Caregivers Is Associated with the Presence of Depressive Symptoms in Stroke Survivors
07:30 AM - 12:00 PM	Abstract	120 - Subpar Utilization of Dental Care among Americans with a History of Stroke
07:30 AM - 12:00 PM	Abstract	121 - Correlations between Stroke Severity and Different Types of Antihyperglycemic Medication
07:30 AM - 12:00 PM	Abstract	122 - Should Provision of Angioplasty for Cerebral Vasospasm Be a Mandatory Component for Hospitals Treating Patients with Subarachnoid Hemorrhage?
07:30 AM - 12:00 PM	Abstract	123 - Health-Related Quality of Life across the Breadth of Neurologic Diseases Seen in the Ambulatory Setting
07:30 AM - 12:00 PM	Abstract	124 - Neurohospitalist Experience in the UK
07:30 AM - 12:00 PM	Abstract	125 - Neurology In-Hospital Fall Risk Assessment: A Role for the Physician
07:30 AM - 12:00 PM	Abstract	126 - Multiple Sclerosis and Vitamin D
07:30 AM - 12:00 PM	Abstract	127 - Survey of outside Physician Calls to University-Based Neurologists
07:30 AM - 12:00 PM	Abstract	128 - Prevalence of Neurological Illness and Associated Mortality on Ugandan Neurology Ward
07:30 AM - 12:00 PM	Abstract	129 - Routine Collection of Health Status Measurs in the Neurologic Population - Is It Feasible?
07:30 AM - 12:00 PM	Abstract	130 - National Institute of Neurological Disorders and Stroke (NINDS), National Institutes of Health (NIH), Common Data Element (CDE) Project: Developing General and Disease-Specific CDEs
07:30 AM - 12:00 PM	Abstract	131 - Long-Term Community Exposure to Drift Containing Organophosphate Pesticides (OP) - Are There Neurobehavioral Effects after Three Decades?
07:30 AM - 12:00 PM	Abstract	132 - Putting AAN-TTA Guidelines on Botulinum Toxin into Clinical Practice
07:30 AM - 12:00 PM	Abstract	133 - Increased Use of Potentially Inappropriate Medications in Patients with Parkinson's Disease
07:30 AM - 12:00 PM	Abstract	134 - Prediction Model of Parkinson's Disease Using Antiparkinsonian Drug Claims
07:30 AM - 12:00 PM	Abstract	135 - A Pharmacoepidemiological Evaluation of Cognitive Impairment-Prescribing Patterns of Dementia Drugs
07:30 AM - 12:00 PM	Abstract	136 - Mild Parkinsonian Signs (MPS) Are Associated with Mild Cognitive Impairment (MCI) but Not Predictive of Progression to Alzheimer's Disease (AD) in a Door-to-Door Study of an Elderly Arab Population
07:30 AM - 12:00 PM	Abstract	137 - Dependence Levels and Risk of Nursing Home Placement or Death in Patients with Alzheimer's Disease
07:30 AM - 12:00 PM	Abstract	138 - Increasing Use of Disease Modifying Drugs for MS in Canada
07:30 AM - 12:00 PM	Abstract	139 - Tolerability, Satisfaction and Discontinuation of Antiepileptic Drugs from the National Survey of Epilepsy, Comorbidities and Health Outcomes (EPIC)
07:30 AM - 12:00 PM	Abstract	140 - Epilepsy and Mortality in Latin America: A Systematic Review
07:30 AM - 12:00 PM	Abstract	142 - National ALS Registry: Lessons from a Pilot Project in the State of Georgia
07:30 AM - 12:00 PM	Abstract	143 - ALS Clinical Phenotypes: A Population-Based Study in Italy
07:30 AM - 12:00 PM	Abstract	144 - Rate of Familial Amyotrophic Lateral Sclerosis - A Systematic Review and Meta-Analysis
07:30 AM - 12:00 PM	Abstract	145 - Beneficial Vascular Risk Profile Is Associated with ALS Susceptibility
07:30 AM - 12:00 PM	Abstract	146 - Platform for Managing Distributed Biological Samples with Ad Hoc Searches from Heterogeneous Data Sources
07:30 AM - 12:00 PM	Abstract	147 - KIFAP3 Has No Effect on Survival in a Population-Based Cohort of ALS Patients
07:30 AM - 12:00 PM	Abstract	148 - Dysregulation of Angiogenin in Amyotrophic Lateral Sclerosis
07:30 AM - 12:00 PM	Abstract	149 - Epidemiology of Amyotrophic Lateral Sclerosis (ALS) in the State of Cear[aacute], Brazil
07:30 AM - 12:00 PM	Abstract	150 - Association of Blood Lead with Risk of Amyotrophic Lateral Sclerosis (ALS)
07:30 AM - 12:00 PM	Abstract	151 - Benign Fasciculation Syndrome: Data from a Neuromuscular Center
07:30 AM - 12:00 PM	Abstract	152 - How Does Direct Care of the Parkinson's Disease Patient Differ between Mid and Late-Stage Disease?
07:30 AM - 12:00 PM	Abstract	153 - Prevalence and Clinical Correlates of Micrographia in Parkinson's Disease
07:30 AM - 12:00 PM	Abstract	154 - Real-Life Driving Outcomes in Mild-Moderate Parkinson's Disease
07:30 AM - 12:00 PM	Abstract	155 - The Effect of Medicare Part D on Parkinson's Disease Patients
07:30 AM - 12:00 PM	Abstract	156 - Is There an Increased Risk of Hip Fracture in Parkinson Disease (PD)? Analysis of the Nationwide Inpatient Sample (NIS)
07:30 AM - 12:00 PM	Abstract	157 - Relationship of Brain Organochlorine Levels with Lewy Pathology: The Honolulu-Asia Aging Study
07:30 AM - 12:00 PM	Abstract	158 - Risk Factors for Parkinson Disease Are Different in Men and Women: A Recursive Partitioning Analysis
07:30 AM - 12:00 PM	Abstract	159 - Predicting Health Status in Parkinson's Disease: What Matters Most?
07:30 AM - 12:00 PM	Abstract	160 - Using Telemedicine to Increase Access to Specialty Care for Individuals with Movement Disorders
07:30 AM - 12:00 PM	Abstract	161 - Effect of Handedness and Side of Onset on Survival in Parkinson's Disease
07:30 AM - 12:00 PM	Abstract	162 - Incidence and Prevalence of Parkinson[acute]s Disease in Buenos Aires City, Argentina
07:30 AM - 12:00 PM	Abstract	163 - Follow-Up of Persons with Neurologic Diseases (FOUND): Remote Follow-Up - A Practical Approach To Maintain Continuous Contact
07:30 AM - 12:00 PM	Abstract	164 - High Prevalence of Hypovitamininosis D Status in Patients with Early Parkinson's Disease from the DATATOP Study
07:30 AM - 12:00 PM	Abstract	165 - Longitudinal Changes in UPSIT Scores
07:30 AM - 12:00 PM	Abstract	166 - Real Life Use of Natalizumab: Results of the Austrian Nationwide Registry
07:30 AM - 12:00 PM	Abstract	167 - Assessing the Risk of Malignancy in Patients with Multiple Sclerosis Receiving Subcutaneous Interferon beta-1a
07:30 AM - 12:00 PM	Abstract	168 - The Oregon Multiple Sclerosis Registry (OMSR) - Preliminary Results
07:30 AM - 12:00 PM	Abstract	169 - Rising Incidence of Multiple Sclerosis in Females along with Urbanization
07:30 AM - 12:00 PM	Abstract	170 - Acute Leukemia in Multiple Sclerosis Patients Treated with Mitoxantrone in the Postmarketing Setting: The EMD Serono Experience
07:30 AM - 12:00 PM	Abstract	171 - Cardiovascular Adverse Events with Mitoxantrone: Results from the Registry To Evaluate Novantrone Effects in Worsening Multiple Sclerosis (RENEW) Study
07:30 AM - 12:00 PM	Abstract	172 - Increased Risk of Multiple Sclerosis among Women with Migraine in the Nurses' Health Study II
07:30 AM - 12:00 PM	Abstract	173 - Individual Based Analysis of Disease Activity in Progressive Multiple Sclerosis
07:30 AM - 12:00 PM	Abstract	174 - Sample Size Estimates for Trials of Neuroprotection in Acute Optic Neuritis
07:30 AM - 12:00 PM	Abstract	175 - Effects of Oral Fingolimod (FTY720) on Pulmonary Function Tests in Patients with Moderate Asthma
07:30 AM - 12:00 PM	Abstract	176 - Multiple Sclerosis Is Increasingly Becoming a Female Disease
07:30 AM - 12:00 PM	Abstract	177 - Diagnostic Accuracy of the Emergency Department in the Multiple Sclerosis Population (Data from the Mount Sinai Resource Utilization in MS Project [RESUMS])
07:30 AM - 12:00 PM	Abstract	178 - Hospital-Based Prevalence and Incidence of Multiple Sclerosis in Chile
07:30 AM - 12:00 PM	Abstract	179 - Prevalence and Incidence of Multiple Sclerosis in Campobasso (Molise Region, Southern Italy)
07:30 AM - 12:00 PM	Abstract	180 - Multiple Sclerosis: Clinical Features and Ethnic Variation in a Multi-Ethnic Community in Northern Sudan
07:30 AM - 12:00 PM	Abstract	181 - Late-Onset Multiple Sclerosis: A Cross-Sectional, Population-Based Study of 1035 Consecutive Patients
07:30 AM - 12:00 PM	Abstract	182 - Emergency Medical Care of Multiple Sclerosis Patients (Data from the Mount Sinai Resource Utilization in MS Project [RESUMS])
07:30 AM - 12:00 PM	Abstract	183 - Early Prediction of Long Term Evolution in Multiple Sclerosis: Application of the Bayesian Risk Estimate for Multiple Sclerosis (BREMS)
07:30 AM - 12:00 PM	Abstract	184 - Impact of Natalizumab on Economic and Clinical Outcomes in MS Patients in the Real-World Setting
07:30 AM - 12:00 PM	Abstract	185 - Preliminary Evaluation of Pregnancy Outcomes from the TYSABRI[reg] (Natalizumab) Pregnancy Exposure Registry
07:30 AM - 12:00 PM	Abstract	186 - Safety and Impact on Disease Outcomes of Natalizumab in Patients with Relapsing-Remitting MS in Clinical Practice
07:30 AM - 12:00 PM	Abstract	187 - Prognostic Factors for Conversion to Clinically Definite Multiple Sclerosis in an Italian Cohort of Subjects with Clinically Isolated Syndromes
07:30 AM - 12:00 PM	Abstract	188 - How Benign Is Benign Multiple Sclerosis?
07:30 AM - 12:00 PM	Abstract	189 - Is the Multiple Sclerosis Severity Score at Initial Presentation to an MS Comprehensive Care Center a Helpful Predictor of Long Term Outcome?
07:30 AM - 12:00 PM	Abstract	190 - Sexuality and Intimacy in MS Patient
07:30 AM - 12:00 PM	Abstract	191 - Sub-Clinical Multiple Sclerosis: Clinical, Neuropsychological and MRI Follow-Up
07:30 AM - 12:00 PM	Abstract	192 - Gender Differences in Sexual Dysfunction of a MS Population
07:30 AM - 12:00 PM	Abstract	193 - Should Primary Multiple Sclerosis Treatment Regimen Be Changed after a Relapse?
07:30 AM - 12:00 PM	Abstract	194 - Motor Disability in Progressive Multiple Sclerosis Is Independently Worsened by Relapses before and after Progression
07:30 AM - 12:00 PM	Abstract	195 - One-Year Prospective Study on Headache Occurrence in Multiple Sclerosis (MS) Patients Treated with Natalizumab
07:30 AM - 12:00 PM	Abstract	196 - Vitamin D Insufficiency in Patients with MS in Southeastern Michigan and Its Relation with Age and Race
07:30 AM - 12:00 PM	Abstract	197 - Utilization of Diagnostic Tests and Procedures for Treated and Untreated Patients with Multiple Sclerosis (MS)
07:30 AM - 12:00 PM	Abstract	198 - Prediction of Disease Progression in Primary Progressive Multiple Sclerosis
07:30 AM - 12:00 PM	Abstract	199 - Sudden Onset Sensorineural Hearing Loss in Multiple Sclerosis: Diagnosis and Prognosis
07:30 AM - 12:00 PM	Abstract	200 - Validation of an Instrumented Gait Measure, the iTUG, in Multiple Sclerosis
07:30 AM - 12:00 PM	Abstract	201 - Relating structural brain damage and functional cortical reorganization in patients with benign MS
07:30 AM - 12:00 PM	Abstract	202 - Assessing Baseline Health and Functional Status of Patients with Multiple Sclerosis: A Pilot Study Using Novel Information Technology
07:30 AM - 12:00 PM	Abstract	203 - Vibration Sensation Thresholds Are Associated with the Sensory Functional System Score of the EDSS in Multiple Sclerosis
07:30 AM - 12:00 PM	Abstract	204 - Impact of Medication Adherence to Disease-Modifying Drugs on Severe Relapse, and Direct and Indirect Costs among Employees with Multiple Sclerosis
07:30 AM - 12:00 PM	Abstract	205 - Health Resource Utilization in the CLARITY Study
07:30 AM - 12:00 PM	Abstract	206 - Clinical Description of Patients Diagnosed with Clinically Probable Psychogenic Movement Disorders in a Movement Disorders Clinic
07:30 AM - 12:00 PM	Abstract	207 - A Brief Structured Questionnaire To Discriminate between Psychogenic and Neurogenic Movement Disorders
07:30 AM - 12:00 PM	Abstract	208 - Psychogenic Non-Epileptic Spells and Movement Disorders in Men
07:30 AM - 12:00 PM	Abstract	209 - Are Disparities in Parkinsonism Diagnoses Due to Underreporting of Symptoms?
07:30 AM - 12:00 PM	Abstract	210 - Quantitative Gait Changes in Probable-RBD Patients in the Mayo Clinic Study of Aging
07:30 AM - 12:00 PM	Abstract	211 - Muted Emotional Enhancement of Memory in Parkinson's Disease
07:30 AM - 12:00 PM	Abstract	212 - Neuropsychological Differences between Parkinson's Disease Patients with Very Mild and Mild Dementia
07:30 AM - 12:00 PM	Abstract	213 - The Pupil as a Measure of Emotion-Modulated Arousal in Parkinson's Disease
07:30 AM - 12:00 PM	Abstract	214 - Is There the Delayed Gastric Emptying of Untreated Patients with Early-Stage Parkinson's Disease? An Analysis Using the 13C-Acetate Breath Test
07:30 AM - 12:00 PM	Abstract	215 - Toys and Gadgets: Construct Validity of Apathy in Parkinson Disease
07:30 AM - 12:00 PM	Abstract	216 - Hallucinations in PD: Ten Year Prospective Longitudinal Assessment
07:30 AM - 12:00 PM	Abstract	217 - Autonomic Insufficiency in Pupillary and Cardiovascular Systems in Parkinson Disease
07:30 AM - 12:00 PM	Abstract	218 - Parkinson's Disease (PD) Increases Risk for Mild Cognitive Impairment (MCI)
07:30 AM - 12:00 PM	Abstract	219 - Nonmotor Symptoms in Parkinson's Disease with Special Reference to Anxiety and Depression
07:30 AM - 12:00 PM	Abstract	220 - Symptoms of Depression More Than Apathy Exhibit Better Neural Reflections of Conflict Processing in Parkinson's Disease (PD)
07:30 AM - 12:00 PM	Abstract	221 - Gray Matter Changes Associated with Early Hallucinations in Parkinson's Disease
07:30 AM - 12:00 PM	Abstract	222 - Predictors of Impulse Control Disorders in MMPI-2 in Patients Suffering from Parkinson[acute]s Disease: A Pilot Study
07:30 AM - 12:00 PM	Abstract	223 - Depression and Autonomic Nerve Dysfunction in Early Parkinson's Disease and Essential Tremor
07:30 AM - 12:00 PM	Abstract	224 - The Addenbrooke[acute]s Cognitive Examination (ACE) Detect Cognitive Impairment in Advanced Parkinson Disease (PD) but Not in Early Parkinson Disease
07:30 AM - 12:00 PM	Abstract	225 - The Iowa Gambling Task and Wisconsin Card Sorting Test Performance Was Modulated by the Presence/Absence of Apathy in Non Depressed Parkinson's Disease Patients
07:30 AM - 12:00 PM	Abstract	227 - Rhinorrhea: A Common Non-Dopaminergic Feature of Parkinson Disease
07:30 AM - 12:00 PM	Abstract	228 - The PARS Study: Evaluating Pre-Clinical Parkinsonian Features in a Healthy Hyposmic Cohort
07:30 AM - 12:00 PM	Abstract	229 - Dimensions of Apathy in Parkinson Disease: Apathy Scale Revisited
07:30 AM - 12:00 PM	Abstract	230 - Divergent Trajectories of Apathy and Depression over Two Years in Medically-Managed, Idiopathic Parkinson's Disease
07:30 AM - 12:00 PM	Abstract	231 - Ropinirole Prolonged Release Improves Mood in Patients with Advanced Parkinson's Disease Not Optimally Controlled with L-Dopa
07:30 AM - 12:00 PM	Abstract	232 - Assessment of Sleep Duration and Nocturnal Awakenings in Patients with Advanced Parkinson's Disease Treated with Adjunctive Ropinirole Prolonged Release
07:30 AM - 12:00 PM	Abstract	233 - Prevalence of Dopamine-Related Behaviour Disorders in Parkinsonian Patients Treated with Continuous Subcutaneous Infusion of Apomorphine
07:30 AM - 12:00 PM	Abstract	234 - Mood and Autonomic Symptom Clusters in Parkinson's Disease
07:30 AM - 12:00 PM	Abstract	235 - The Quantitative Pull Test: A Method To Measure Parkinsonian Postural Instability
07:30 AM - 12:00 PM	Abstract	236 - A Comparison of Prevalence of Non-Motor Symptoms in Movement Disorders
07:30 AM - 12:00 PM	Abstract	237 - Parkinson Movement Tests Performance: Feasibility and Reliability of Video Feature Extraction for Quantization of Standard Test Movements
07:30 AM - 12:00 PM	Abstract	238 - Neurophysiological Correlates of Over-Inhibition in Apathetic Parkinson's Disease Patients
07:30 AM - 12:00 PM	Abstract	240 - Effect of Rotigotine on Sleep Quality and Control of Early Morning Motor Function in Subjects with Idiopathic Parkinson's Disease
07:30 AM - 12:00 PM	Abstract	241 - Tracking Cognitive Change on the MMSE and MoCA in Parkinson's Disease
07:30 AM - 12:00 PM	Abstract	242 - Digital Voice Analysis in Patients with Parkinson's Disease (PD)
07:30 AM - 12:00 PM	Abstract	243 - Binge Eating in Parkinson Disease: Prevalence, Correlates and the Contribution of Deep Brain Stimulation
07:30 AM - 12:00 PM	Abstract	244 - Which Nonmotor Signs Can Best Discriminate Early Parkinson's Disease? A Case-Control Study
07:30 AM - 12:00 PM	Abstract	245 - Mood and Neurocognitive Contributions to a Dementia Screening Scale in Patients with Parkinson's Disease
07:30 AM - 12:00 PM	Abstract	246 - Amiloride Accelerates MPTP-Induced Cell Death in the Human Dopaminergic SHSY-5Y Cells Overexpressed with Acid-Sensitive Ion Channel (ASIC)1a
07:30 AM - 12:00 PM	Abstract	247 - Role of Dynein Dysfunction in Autophagic Stress and Neurodeneration In Vivo and Vitro Involved in Parkinson's Disease
07:30 AM - 12:00 PM	Abstract	248 - Interaction of Parkinson's Disease and Age in Pre-Supplementary Motor Area Cortical Thickness
07:30 AM - 12:00 PM	Abstract	249 - Brainstem Myoinositol as a Biomarker of Disease Severity in MSA-C: A 3 T 1H-MRS Study
07:30 AM - 12:00 PM	Abstract	250 - The Hematopoietic Growth Factor G-CSF Enhances Recovery in the MPTP Mouse Model of PD
07:30 AM - 12:00 PM	Abstract	251 - Ubiquitin Proteasome System Impairment Mouse Model of Parkinson's Disease
07:30 AM - 12:00 PM	Abstract	252 - Development and Evaluation of Allosteric Modulators of Dopamine D2 Receptors in Pre-Clinical Rat Models: Implications for the Treatment of Parkinson's Disease and Drug Induced Dyskinesia
07:30 AM - 12:00 PM	Abstract	253 - Next-Generation Sequencing Allows for Comprehensive Detection of Mitochondrial Variation in Brain Tissue
07:30 AM - 12:00 PM	Abstract	254 - Detection of Polyglutamine Protein Oligomers in Living Cells Using Protein-Fragment Complementation Assays
07:30 AM - 12:00 PM	Abstract	255 - Reduced Dopamine Transporter Density in the Ventral Striatum of Patients with Parkinson's Disease and Impulse Control Disorders: A Voxel-Wise Analysis
07:30 AM - 12:00 PM	Abstract	256 - Selective Metabotropic Glutamate Receptor 5 (mGlu5) Antagonism Reduces L-DOPA-Induced Dyskinesia in MPTP-Lesioned Primates at the Expense of Anti-Parkinsonian Benefit
07:30 AM - 12:00 PM	Abstract	257 - Ratings of "Mental Rigidity" Reflect Cholinergic Rather Than Dopaminergic Denervation in Parkinson Disease
07:30 AM - 12:00 PM	Abstract	258 - Critical Alterations in the Basal Ganglia Pathophysiology in Parkinson's Disease. A Computational Model Approach
07:30 AM - 12:00 PM	Abstract	259 - Glycine Receptor Antibodies in Immune-Mediated Movement Disorders: Progressive Encephalomyelitis with Rigidity and Myoclonus, Opsoclonus-Myoclonus Syndrome, and Ocular Flutter Syndrome
07:30 AM - 12:00 PM	Abstract	260 - Two Parkinson's Disease Patients with [alpha]-Synuclein Gene Duplication and Rapid Cognitive Decline
07:30 AM - 12:00 PM	Abstract	261 - Evaluation of SNCA CpG Island Methylation Level in Post-Mortem Brain of Parkinson's Disease and Dementia with Lewy Bodies
07:30 AM - 12:00 PM	Abstract	262 - CD-PROBE (Cervical Dystonia Patient Registry for Observation of BOTOX[reg] Efficacy) [mdash] A Multicenter, Observational Study of Repeated OnabotulinumtoxinA Injections in Cervical Dystonia (CD) Patients - Preliminary Baseline Data
07:30 AM - 12:00 PM	Abstract	263 - Why Do Cervical Dystonia Patients Leave Academic Movement Disorders Clinics?
07:30 AM - 12:00 PM	Abstract	264 - An Open-Label Safety and Immunogenicity Study of NeuroBloc[reg] (MYOBLOC[reg]; RimabotulinumtoxinB; BoNT-B) in Patients with Cervical Dystonia (CD) (401CD-EU)
07:30 AM - 12:00 PM	Abstract	265 - An Open-Label, Safety and Immunogenicity Study of Myobloc[reg] (RimabotulinumtoxinB; BoNT-B) in Patients with Cervical Dystonia - (351)
07:30 AM - 12:00 PM	Abstract	266 - A 7-Year Open-Label Safety and Immunogenicity Study of Myobloc[reg] (RimabotulinumtoxinB; BoNT-B) in Patients with Cervical Dystonia - (401CD-NA)
07:30 AM - 12:00 PM	Abstract	267 - Quantification of Cervical Dystonia and Response to Botulinum Toxin Using Electrical Impedance Myography
07:30 AM - 12:00 PM	Abstract	268 - Efficacy of NT 201 (Botulinum Neurotoxin Type A Free from Complexing Proteins) in the Treatment of Patients with Focal Dystonia
07:30 AM - 12:00 PM	Abstract	269 - Immunogenicity Analysis from a Randomized, Double-Blind Study To Compare the Efficacy and Safety of NeuroBloc[reg] (Myobloc/RimabotulinumtoxinB;BoNT-B) with OnabotulinumtoxinA (Botox[reg]; BoNT-A) in Patients with Cervical Dystonia (CD) Who Have Never Previously Received a Botulinum Toxin Product (402CD-EU)
07:30 AM - 12:00 PM	Abstract	270 - Safety and Efficacy of Repeated NT 201 (Botulinum Neurotoxin Type A Free from Complexing Proteins) Injections of Patients with Cervical Dystonia: A First Long-Term Safety Analysis
07:30 AM - 12:00 PM	Abstract	271 - Presence of Neutralising Antibodies in a Patient Population with Cervical Dystonia Prior to Clinical Study Entry
07:30 AM - 12:00 PM	Abstract	272 - The Utility of Visual, Tactile and Mixed Tasks in the Determination of Temporal Discrimination Thresholds in Adult-Onset Primary Torsion Dystonia
07:30 AM - 12:00 PM	Abstract	273 - Clinical Subtypes of Disproportionate Anterocollis in Parkinsonian Syndromes
07:30 AM - 12:00 PM	Abstract	274 - Seroconversion in Cervical Dystonia Patients after Treatment with Abobotulinumtoxin A
07:30 AM - 12:00 PM	Abstract	275 - Efficacy of AbobotulinumtoxinA for the Treatment of Cervical Dystonia: Analysis by Patient Sub-Population
07:30 AM - 12:00 PM	Abstract	276 - CD-PROBE (Cervical Dystonia Patient Registry for Observation of BOTOX[reg] Efficacy) [mdash] A Multicenter, Observational Study of OnabotulinumtoxinA Injections in Cervical Dystonia (CD) Patients - Interim Patient Reported Outcome Data
07:30 AM - 12:00 PM	Abstract	278 - Asian Over-Representation among Patients with Hemifacial Spasm Compared to Cranial Dystonia
07:30 AM - 12:00 PM	Abstract	279 - Swallowing Induced Laryngo-Pharyngeal Movement - A New Variant of Focal PKD?
07:30 AM - 12:00 PM	Abstract	280 - Curcumin Prevents the Development of Vacuous Chewing Movements in a Preclinical Animal Model of Human Tardive Dyskinesia and Proteomic Array Reveals a Possible Role of Target Proteins in the Mechanism of Action
07:30 AM - 12:00 PM	Abstract	281 - Increasing Incidence of Seropositive Myasthenia Gravis in British Columbia, Canada: A 25 Year Population Based Study
07:30 AM - 12:00 PM	Abstract	282 - Cardiomyopathy in Myasthenia Gravis: The Frequency and Characteristics
07:30 AM - 12:00 PM	Abstract	283 - Clinical Course of Patients with Myasthenia Gravis in a Regional Hospital in Hong Kong: A Retrospective Review
07:30 AM - 12:00 PM	Abstract	284 - Differences in Clinical and Immunological Profiles between Early and Late-Onset Myasthenia Gravis in Japan
07:30 AM - 12:00 PM	Abstract	285 - Striated Muscle Antibodies: Clinical Features and Utility in Myasthenia Gravis
07:30 AM - 12:00 PM	Abstract	286 - MuSK-Antibody Positive Myasthenia Gravis and Their Clinical Features in North India
07:30 AM - 12:00 PM	Abstract	287 - Muscle Specific Tyrosine Kinase Antibody Positivity: Prevalence and Clinical Characteristics in Western Canada
07:30 AM - 12:00 PM	Abstract	288 - Novel Acetylcholinesterase Inhibitors in Myasthenia Patients: Four Year Follow-Up
07:30 AM - 12:00 PM	Abstract	289 - Benefits from Sustained-Release Pyridostigmine Bromide in Myasthenia Gravis. Results of a Prospective Multicenter Open-Label Trial
07:30 AM - 12:00 PM	Abstract	290 - Rituximab in Generalized Myasthenia Gravis
07:30 AM - 12:00 PM	Abstract	291 - Response of Patients with Refractory Myasthenia Gravis Treated with Ritxuimab
07:30 AM - 12:00 PM	Abstract	292 - Multi-Target Treatment for Refractory Myasthenia Gravis
07:30 AM - 12:00 PM	Abstract	293 - Trends in Outcomes and Hospitalization Cost of Adult Patients with Botulism in the United States
07:30 AM - 12:00 PM	Abstract	294 - Regulatory role of short interval cortical inhibition during somatosensory evoked motor cortex plasticity

Faculty Disclosures
David C. Preston, MD, FAAN	Dr. Preston has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for FBI, US Attorney, Insurance Fraud Investigative Units. Dr. Preston has received publishing royalties from a publication relating to health care.
Theresa A. Zesiewicz, MD	Dr. Zesiewicz has received personal compensation for serving as an employee of Medscape. Dr. Zesiewicz has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Lexeo. Dr. Zesiewicz has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Steminent. Dr. Zesiewicz has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Larimar. Dr. Zesiewicz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biohaven. Dr. Zesiewicz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Zesiewicz has received intellectual property interests from a discovery or technology relating to health care. Dr. Zesiewicz has received intellectual property interests from a discovery or technology relating to health care. Dr. Zesiewicz has received intellectual property interests from a discovery or technology relating to health care.
Anthony E. Lang, MD, FAAN	Dr. Lang has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AbbVie, Amylyx, Aprinoia, Biogen, BioAdvance, Biohaven, BioVie, BlueRock, BMS, Denali, Janssen, Lilly, Pharma 2B, Sun Pharma, and UCB. Dr. Lang has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for medicolegal cases related to paraquat. The institution of Dr. Lang has received research support from AbbVie. Dr. Lang has received intellectual property interests from a discovery or technology relating to health care. Dr. Lang has received publishing royalties from a publication relating to health care.
Henry J. Kaminski, MD, FAAN	Dr. Kaminski has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Kaminski has received personal compensation in the range of $0-$499 for serving as a Consultant for Cabaletta Bio. The institution of Dr. Kaminski has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Kaminski has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Canopy Immunotherapeutics. Dr. Kaminski has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Curie.bio. Dr. Kaminski has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Samsung. Dr. Kaminski has received personal compensation in the range of $0-$499 for serving as a Consultant for Care Constitution. Dr. Kaminski has stock in mimivax. The institution of Dr. Kaminski has received research support from National Institutes of Health. Dr. Kaminski has received publishing royalties from a publication relating to health care.
Christopher Goetz, MD, FAAN	The institution of Dr. Goetz has received research support from Michael J. Fox Foundation. The institution of Dr. Goetz has received research support from NIH. The institution of Dr. Goetz has received research support from Department of Defense. Dr. Goetz has received publishing royalties from a publication relating to health care. Dr. Goetz has received publishing royalties from a publication relating to health care. Dr. Goetz has received publishing royalties from a publication relating to health care.
David P. Richman, MD, FAAN	The institution of Dr. Richman has received research support from Muscular Dystrophy Association.
Cynthia L. Comella, MD, FAAN	Dr. Comella has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Ipsen. Dr. Comella has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vima. Dr. Comella has received publishing royalties from a publication relating to health care. Dr. Comella has received publishing royalties from a publication relating to health care.
Ronald C. Petersen, MD, PhD, FAAN	Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly and Co.. Dr. Petersen has received personal compensation in the range of $0-$499 for serving as a Consultant for Eisai, Inc.. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novo Nordisk. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Petersen has received publishing royalties from a publication relating to health care. Dr. Petersen has received publishing royalties from a publication relating to health care. Dr. Petersen has received publishing royalties from a publication relating to health care. Dr. Petersen has a non-compensated relationship as a Board of Directors with American Brain Foundation that is relevant to AAN interests or activities.
Henry L. Paulson, MD, PhD, FAAN	Dr. Paulson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Exicure. The institution of Dr. Paulson has received research support from National Institutes of Health. Dr. Paulson has a non-compensated relationship as a Member, Nominating committee with American Neurological Association that is relevant to AAN interests or activities.
Cherylee Chang, MD	Dr. Chang has a non-compensated relationship as a Member, Board of Directors (Council); Treasurer; President-Elect with Society of Critical Care Medicine that is relevant to AAN interests or activities.
Paul E. Greene, MD	No disclosure on file
David L. Tirschwell, MD, FAAN	Dr. Tirschwell has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boston Scientific. The institution of Dr. Tirschwell has received research support from Abbott. The institution of Dr. Tirschwell has received research support from NIH.
Joseph Jankovic, MD, FAAN	Dr. Jankovic has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Revance. Dr. Jankovic has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Revance, Allergan. The institution of Dr. Jankovic has received research support from Baylor College of Medicine. Dr. Jankovic has received research support from Abbvie. The institution of Dr. Jankovic has received research support from Abbvie.
Mark B. Bromberg, MD, PhD, FAAN	Dr. Bromberg has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Accordant Health. Dr. Bromberg has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Bromberg has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Argenx. Dr. Bromberg has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Takeda. Dr. Bromberg has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Grifols. Dr. Bromberg has received publishing royalties from a publication relating to health care. Dr. Bromberg has received publishing royalties from a publication relating to health care. Dr. Bromberg has received publishing royalties from a publication relating to health care. Dr. Bromberg has received personal compensation in the range of $5,000-$9,999 for serving as a Medical reviewer with Department of Justice, Vaccination Compensation Board.
Douglas I. Katz, MD, FAAN	Dr. Katz has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Law firms. The institution of Dr. Katz has received research support from NINDS/NIH. Dr. Katz has received publishing royalties from a publication relating to health care.
Cheryl Bushnell, MD, MHS	The institution of Dr. Bushnell has received research support from PCORI. The institution of Dr. Bushnell has received research support from NIH/NINDS. Dr. Bushnell has received intellectual property interests from a discovery or technology relating to health care. Dr. Bushnell has received publishing royalties from a publication relating to health care.
Larry B. Goldstein, MD, FAHA, FAAN	The institution of Dr. Goldstein has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. The institution of Dr. Goldstein has received research support from NIH. The institution of Dr. Goldstein has received research support from NIH. Dr. Goldstein has received intellectual property interests from a discovery or technology relating to health care. Dr. Goldstein has received publishing royalties from a publication relating to health care.
Jose Biller, MD, FACP, FAHA, FAAN	Dr. Biller has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wolters Kluwer. Dr. Biller has received publishing royalties from a publication relating to health care.
John W. Engstrom, MD, FAAN	Dr. Engstrom has nothing to disclose.
Jeffrey L. Saver, MD, FAAN	Dr. Saver has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medtronic. Dr. Saver has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Stryker. Dr. Saver has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cerenovus. Dr. Saver has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Boehringer Ingelheim (prevention only). Dr. Saver has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Medical Association. Dr. Saver has received stock or an ownership interest from Rapid Medical.
Jacqueline French, MD, FAAN	Dr. French has received personal compensation in the range of $50,000-$99,999 for serving as an officer or member of the Board of Directors for Epilepsy Foundation. The institution of Dr. French has received research support from Epilepsy Study Consortium/ Epilepsy Foundation (Funded by UCB). The institution of Dr. French has received research support from GW/One8 Foundation/FACES. The institution of Dr. French has received research support from NINDS. The institution of Dr. French has received research support from Xenon. The institution of Dr. French has received research support from Cerevel. The institution of Dr. French has received research support from FACES. The institution of Dr. French has received research support from UCB. The institution of Dr. French has received research support from Epilepsy Study Consortium. The institution of Dr. French has received research support from UCB. The institution of Dr. French has received research support from Praxis. Dr. French has received personal compensation in the range of $50,000-$99,999 for serving as a Chief Medical/Innovation Officer with Epilepsy Foundation. Dr. French has a non-compensated relationship as a Consultant with Acadia Pharmaceuticals Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant with Access Industries that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant with Acuta Capital Partners LLC that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with AFASCI Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Agrithera, Inc. that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Alkermes that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant with Alterity Therapeutics Limited that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Angelini Pharma S.p.A. that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Autifony Therapeutics Limited that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Axonis Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Bain Capital that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Beacon Biosciences that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Biogen that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Biohaven Pharma that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Bloom Science, Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Bright Minds Biosciences, Inc. that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Capsidia Biotherapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Cerebral Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Cerecin, Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, SAB with Cerevel that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consulting, SAB with Cognizance Biomarkers that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consulting with Ceribell that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Cowen that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Crossject that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Advisory Board with EcoR1 Capital that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with EG 427 that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant, Advisory Board with Eisai that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Encoded Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant/Advisory Board with Engrail that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Epitel, Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with EpiMinder that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Grin Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Harmony that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Advisory Board with Ionis Pharmaceutical that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with iQure Pharma, Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with IQVIA that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Janssen Pharma that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Jazz Pharmaceutical that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Leal Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, with Livanova that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, SAB with London Research & Pharmaceuticals that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Longboard Pharmaceutical that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Maplight Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Marinus that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Medscape/Web MD that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant with Modulight Bio that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Montara Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Mosaica Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant with Neumarker that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Neumirna Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Neurelis that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consulting, Advisory Board with Neurocrine that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant with Neuropace that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with NeuroPro Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consulting with Neuroventis that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consulting with Neurona Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consulting, Advisory Board with Neuvarti that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Noema that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consulting with Ono Pharmaceutical that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consulting, Advisory Board with Otsuka that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consulting, Advisory Board with Ovid Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consulting with Praxis that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with PureTech LYT Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with QurAlis Corp that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Rapport Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Receptor Holdings, Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Rivervest Venture Partners that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Sage Therapeutics, Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with SK Life Science that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Stoke that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Stream Neuroscience that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Supernus that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Takeda that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Taysha Gene Therapies that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with UCB, Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with uniQure that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Ventus Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Vida Ventures Management that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Xenon Pharmaceuticals that is relevant to AAN interests or activities.
Mark Stacy, MD	Dr. Stacy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biovie. Dr. Stacy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for National Institute of Aging. Dr. Stacy has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Dartmouth. Dr. Stacy has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Movement Disorders Journal.
Cathy A. Sila, MD, FAAN	Dr. Sila has nothing to disclose.
Virgilio Gerald H. Evidente, MD, FAAN	Dr. Evidente has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Revance. Dr. Evidente has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Evidente has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Supernus. Dr. Evidente has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Teva. Dr. Evidente has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Medtronic. Dr. Evidente has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Neurocrine. Dr. Evidente has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amneal. Dr. Evidente has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie. The institution of Dr. Evidente has received research support from CND. The institution of Dr. Evidente has received research support from Aeon. The institution of Dr. Evidente has received research support from Bukwang Pharmaceuticals. The institution of Dr. Evidente has received research support from Jazz Pharmaceuticals. The institution of Dr. Evidente has received research support from Scion Neurostim. The institution of Dr. Evidente has received research support from Theravance Biopharma. Dr. Evidente has received research support from Cerevance. Dr. Evidente has received research support from Ipsen. The institution of Dr. Evidente has received research support from Vima Pharmaceuticals. The institution of Dr. Evidente has received research support from Biohaven.
Seward B. Rutkove, MD, FAAN	Dr. Rutkove has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Myolex, Inc. Dr. Rutkove has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Academy of Neuorlogy . The institution of Dr. Rutkove has received research support from NIH. The institution of Dr. Rutkove has received research support from NASA. The institution of Dr. Rutkove has received research support from Blavatnik Family Foundation. Dr. Rutkove has received intellectual property interests from a discovery or technology relating to health care. Dr. Rutkove has received intellectual property interests from a discovery or technology relating to health care. Dr. Rutkove has received publishing royalties from a publication relating to health care. Dr. Rutkove has received publishing royalties from a publication relating to health care. Dr. Rutkove has received personal compensation in the range of $500-$4,999 for serving as a Grant Reviewer with NIH.
Karl D. Kieburtz, MD	Dr. Kieburtz has received personal compensation for serving as an employee of Clintrex Research Corporation. Dr. Kieburtz has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Kieburtz has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly. Dr. Kieburtz has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Dr. Kieburtz has stock in Clintrex Research Corp. Dr. Kieburtz has stock in Hoover Brown. An immediate family member of Dr. Kieburtz has stock in Hoover Brown. Dr. Kieburtz has stock in Safe Therapeutics. The institution of Dr. Kieburtz has received research support from NIH. The institution of Dr. Kieburtz has received research support from Michae J Fox Foundation.
Henry F. McFarland, MD	Dr. McFarland has received intellectual property interests from a discovery or technology relating to health care. Dr. McFarland has received personal compensation in the range of $50,000-$99,999 for serving as a Medical Director with Cumming Foundation.
Ruth Ottman, PhD	No disclosure on file
Stephan A. Mayer, MD	Dr. Mayer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ceribell. Dr. Mayer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Phagenesis. Dr. Mayer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ISchemaView. Dr. Mayer has stock in Neuroptics. Dr. Mayer has received publishing royalties from a publication relating to health care.
Daniel Woo, MD, FAAN	The institution of Dr. Woo has received research support from NIH.
Richard M. Dubinsky, MD, MPH, FAAN	Dr. Dubinsky has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie Pharmaceuticals. An immediate family member of Dr. Dubinsky has stock in Abbvie and Abbott Labs. The institution of Dr. Dubinsky has received research support from CHDI. The institution of Dr. Dubinsky has received research support from Prilenia. The institution of Dr. Dubinsky has received research support from Sage Pharmaceuticals. The institution of Dr. Dubinsky has received research support from NIH/NINDS. Dr. Dubinsky has a non-compensated relationship as a Member, independent data safety monitoring board with Roche that is relevant to AAN interests or activities.
Jody Corey-Bloom, MD, PhD, FAAN	Dr. Corey-Bloom has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UniQure. Dr. Corey-Bloom has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Teva Pharmaceuticaks. Dr. Corey-Bloom has received personal compensation in the range of $10,000-$49,999 for serving as a Co-Director, HD-Net with Huntington Study Group.
Samuel Wiebe, MD	Dr. Wiebe has a non-compensated relationship as a Past President with International League Against Epilepsy that is relevant to AAN interests or activities.
Caroline M. Tanner, MD, PhD, FAAN	Dr. Tanner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Evidera. Dr. Tanner has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurocrine. Dr. Tanner has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Jazz Pharmaceuticals/Cavion. Dr. Tanner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bial . Dr. Tanner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Supernus. Dr. Tanner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche Genentech. The institution of Dr. Tanner has received research support from Gateway LLC. The institution of Dr. Tanner has received research support from Roche\Genentech. The institution of Dr. Tanner has received research support from Michael J Fox Foundation . The institution of Dr. Tanner has received research support from National Institute of Health . The institution of Dr. Tanner has received research support from Department of Defense. Dr. Tanner has received personal compensation in the range of $500-$4,999 for serving as a Faculty, CME presentation with Medscape /WebND.
Eelco F. Wijdicks, MD, FAAN	Dr. Wijdicks has received publishing royalties from a publication relating to health care.
Hubert H. Fernandez, MD, FAAN	Dr. Fernandez has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Fernandez has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amneal. Dr. Fernandez has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Intrance. Dr. Fernandez has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Fernandez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Dr. Fernandez has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Fernandez has received publishing royalties from a publication relating to health care. Dr. Fernandez has received personal compensation in the range of $10,000-$49,999 for serving as a Steering Committee/Advisory Committee Member with Parkinson Study Group.
Hamza I. Maqsood, MD	Dr. Qureshi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AstraZeneca.
Matthew Rizzo, MD, FAAN	The institution of Dr. Rizzo has received research support from NIH.
Safwan S. Jaradeh, MD, FAAN	Dr. Jaradeh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alnylam. Dr. Jaradeh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Akcea. Dr. Jaradeh has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alnylam & Akcea. The institution of Dr. Jaradeh has received research support from Alnylam.
Michel T. Torbey, MD, MPH, FAAN	Dr. Torbey has nothing to disclose.
Charles H. Adler, MD, PhD, FAAN	Dr. Adler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amneal. Dr. Adler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avion. Dr. Adler has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for CND Life Sci. Dr. Adler has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Jazz. Dr. Adler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Precon. Dr. Adler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurocrine. The institution of Dr. Adler has received research support from NIH. The institution of Dr. Adler has received research support from Michael J. Fox Foundation. The institution of Dr. Adler has received research support from Arizona Biomedical Research Commission. Dr. Adler has received publishing royalties from a publication relating to health care.
Claudia Kawas, MD	The institution of Dr. Kawas has received research support from NIH.
Daniel Tarsy, MD, FAAN	No disclosure on file
Lawrence R. Wechsler, MD, FAAN	Dr. Wechsler has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Neurological Association. Dr. Wechsler has stock in Forest Devices.
Wendy Peltier, MD	No disclosure on file
Dennis N. Bourdette, MD, FAAN	Dr. Bourdette has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Magellan Health Care. Dr. Bourdette has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Best Doctor's Inc. Dr. Bourdette has stock in Authobahn Therapeutics. Dr. Bourdette has received intellectual property interests from a discovery or technology relating to health care.
Stanley Fahn, MD, FAAN	Dr. Fahn has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Stoparkinson Healthcare Systems, LLC; . Dr. Fahn has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Retrophin Inc . Dr. Fahn has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer Publishers . Dr. Fahn has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Kirkland & Ellis. Dr. Fahn has received publishing royalties from a publication relating to health care.
Maria Corrada, PhD	The institution of Dr. Corrada has received research support from NIH.
Ilo Leppik, MD	Dr. Leppik has nothing to disclose.
Brett M. Kissela, MD, MS, FAAN	The institution of Dr. Kissela has received research support from NIH/NINDS. Dr. Kissela has a non-compensated relationship as a Board Member with AHA Regional Board that is relevant to AAN interests or activities.
Daniel L. Murman, MD, FAAN	The institution of Dr. Murman has received research support from Biogen. The institution of Dr. Murman has received research support from EIP Pharma. The institution of Dr. Murman has received research support from Eli Lilly & Co.. The institution of Dr. Murman has received research support from Functional Neuromodulation. The institution of Dr. Murman has received research support from Roche Pharmaceuticals.
	No disclosure on file
Aikaterini Kompoliti, MD, FAAN	Dr. Kompoliti has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Kompoliti has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neurocrine. Dr. Kompoliti has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Scion. Dr. Kompoliti has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Emalex. Dr. Kompoliti has received research support from Emalex. Dr. Kompoliti has received research support from TEVA. Dr. Kompoliti has received research support from Theravance. Dr. Kompoliti has received research support from Ipsen. Dr. Kompoliti has received research support from Theravance.
Helmi L. Lutsep, MD, FAAN	Dr. Lutsep has received personal compensation in the range of $0-$499 for serving as a Consultant for Abbott. Dr. Lutsep has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS. Dr. Lutsep has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Coherex Medical. Dr. Lutsep has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NINDS/Mayo Cinic. Dr. Lutsep has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Medscape Neurology.
Jean P. Hubble, MD	No disclosure on file
Viken L. Babikian, MD, FAAN	Dr. Babikian has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boston Scientific. Dr. Babikian has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Baim Institute for Clinical Research. Dr. Babikian has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Boston Scientific.
Irene Litvan, MD, FAAN	Dr. Litvan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Aprinoia. Dr. Litvan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Litvan has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Frontiers in Neurology. Dr. Litvan has received personal compensation in the range of $50,000-$99,999 for serving as a Chief Editor with Frontiers in Neurology.
Joseph P. Broderick, MD, FAAN	The institution of Dr. Broderick has received research support from Novo Nordisk. Dr. Broderick has received publishing royalties from a publication relating to health care.
Ira Shoulson, MD	Dr. Shoulson has received research support from Vaccinex.
Charles H. Tegeler, MD	Dr. Tegeler has nothing to disclose.
Eric L. Logigian, MD, FAAN	Dr. Logigian has nothing to disclose.
John N. Caviness, MD, FAAN	Dr. Caviness has nothing to disclose.
Stacy A. Rudnicki, MD, FAAN	Dr. Rudnicki has received personal compensation for serving as an employee of Cytokinetics. Dr. Rudnicki has stock in Cytokinetics.
Edward M. Manno, MD, FAAN	No disclosure on file
Robert P. Friedland, MD, FAAN	No disclosure on file
J. T. Greenamyre, MD, PhD	The institution of Dr. Greenamyre has received research support from NIH. The institution of Dr. Greenamyre has received research support from Michael J Fox Foundation. The institution of Dr. Greenamyre has received research support from Calico Life Sciences. The institution of Dr. Greenamyre has received research support from Acurex.
Michael G. Halmagyi, MD	Dr. Halmagyi has nothing to disclose.
David I. Kaufman, DO	Dr. Kaufman has nothing to disclose.
Leon S. Dure, MD	Dr. Dure has nothing to disclose.
Nancy D. Richert, MD, PhD	No disclosure on file
Kristine Yaffe, MD	Dr. Yaffe has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly. Dr. Yaffe has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Quintiles. Dr. Yaffe has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Alector. The institution of Dr. Yaffe has received research support from NIH. The institution of Dr. Yaffe has received research support from DOD. The institution of Dr. Yaffe has received research support from Veterans Affairs.
Tudor G. Jovin, MD	Dr. Jovin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cerenovus. Dr. Jovin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Contego Medical. Dr. Jovin has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Several law firms. Dr. Jovin has stock in Corindus. Dr. Jovin has stock in Methinks. Dr. Jovin has stock in Viz.ai. Dr. Jovin has stock in Route92. Dr. Jovin has stock in FreeOx Biotech. Dr. Jovin has stock in Galaxy. Dr. Jovin has stock in Kandu. The institution of Dr. Jovin has received research support from Stryker. The institution of Dr. Jovin has received research support from Medtronic.
Anthony J. Furlan, MD, FAAN	No disclosure on file
Bernard M. Ravina, MD, MSCE	Dr. Ravina has received personal compensation for serving as an employee of Praxis Precision Medicines. Dr. Ravina has stock in Praxis.
Gretchen E. Tietjen, MD	An immediate family member of Dr. Tietjen has stock in Johnson & Johnson.
Orhun H. Kantarci, MD	Dr. Kantarci has nothing to disclose.
Nerses Sanossian, MD, FAAN	Dr. Sanossian has received personal compensation for serving as an employee of Univeristy of Southern California. Dr. Sanossian has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medtronic. Dr. Sanossian has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genentech. Dr. Sanossian has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Portola. The institution of Dr. Sanossian has received research support from Diffusion Pharma.
Nathalie Jette, MD, MSc, FRCPC, FAAN	Dr. Jette has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for ILAE Epilepsia. The institution of Dr. Jette has received research support from NIH. The institution of Dr. Jette has received research support from AES.
Samay Jain, MD	No disclosure on file
Charlene Gamaldo, MD, FAAN	Dr. Gamaldo has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for johns hopkins. Dr. Gamaldo has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Jazz. Dr. Gamaldo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda. Dr. Gamaldo has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Apnimed. The institution of Dr. Gamaldo has received research support from NIH/NIMH/NIDA/NINDS. Dr. Gamaldo has received publishing royalties from a publication relating to health care.
Imad M. Najm, MD	Dr. Najm has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eisai Inc. Dr. Najm has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai Inc. Dr. Najm has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Eisai Inc.
Douglas Galasko, MD	Dr. Galasko has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eisai. Dr. Galasko has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly, Inc. Dr. Galasko has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche Diagnostics. Dr. Galasko has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cognition THeraprutics. Dr. Galasko has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Artery Therapeutics.
Matthew B. Stern, MD	Dr. Stern has received personal compensation for serving as an employee of Mediflix, Inc. Dr. Stern has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for biogen. Dr. Stern has received personal compensation in the range of $100,000-$499,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neuroderm.
Salah G. Keyrouz, MD	No disclosure on file
Gena R. Ghearing, MD	The institution of Dr. Ghearing has received research support from Center for Disease Control and Prevention.
Renato P. Munhoz, MD, PhD	Dr. Munhoz has nothing to disclose.
Rishi Gupta, MD	No disclosure on file
Howard J. Rosen, MD	Dr. Rosen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly . Dr. Rosen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alector. The institution of Dr. Rosen has received research support from NIH. The institution of Dr. Rosen has received research support from State of CA. Dr. Rosen has a non-compensated relationship as a Consultant with Prevail Therapeutics that is relevant to AAN interests or activities. Dr. Rosen has a non-compensated relationship as a consultant with Alchemab that is relevant to AAN interests or activities.
John Corboy, MD, FAAN	Dr. Corboy has received personal compensation for serving as an employee of U of Coloado. Dr. Corboy has received personal compensation for serving as an employee of Rocky Mountain MS Center. Dr. Corboy has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Mylan. Dr. Corboy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squib. Dr. Corboy has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN. Dr. Corboy has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Neurological Association. Dr. Corboy has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Mylan. The institution of Dr. Corboy has received research support from MedDay. The institution of Dr. Corboy has received research support from Novartis. The institution of Dr. Corboy has received research support from NMSS. The institution of Dr. Corboy has received research support from PCORI. The institution of Dr. Corboy has received research support from EMD Serono.
Andres Gonzalez, MD, FAAN	Dr. Gonzalez has nothing to disclose.
Kottil W. Rammohan, MD	Dr. Rammohan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Rammohan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Rammohan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Rammohan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion. Dr. Rammohan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genzyme. Dr. Rammohan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMD Serono. The institution of Dr. Rammohan has received research support from Genentech. The institution of Dr. Rammohan has received research support from Genzyme. The institution of Dr. Rammohan has received research support from EMD Serono. The institution of Dr. Rammohan has received research support from Alexion.
Giancarlo Logroscino, MD, PhD, FAAN	Dr. Logroscino has nothing to disclose.
Jeffery Vance, MD, PhD	Dr. Vance has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for neurology genetics.
Neeraj Badjatia, MD	The institution of Dr. Badjatia has received research support from NIH/DOD.
David M. Greer, MD, FAAN	Dr. Greer has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Thieme, Inc. Dr. Greer has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for multiple. Dr. Greer has received publishing royalties from a publication relating to health care. Dr. Greer has received publishing royalties from a publication relating to health care. Dr. Greer has received publishing royalties from a publication relating to health care. Dr. Greer has a non-compensated relationship as a Treasurer-Elect with American Neurological Association that is relevant to AAN interests or activities. Dr. Greer has a non-compensated relationship as a President with Neurocritical Care Society that is relevant to AAN interests or activities.
Michael S. Okun, MD, FAAN	Dr. Okun has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for NIH. Dr. Okun has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Parkinson's Foundation. Dr. Okun has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for JAMA Neurology. Dr. Okun has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for NEJM Journal Watch. The institution of Dr. Okun has received research support from NIH. The institution of Dr. Okun has received research support from Parkinson's Foundation. The institution of Dr. Okun has received research support from Tourette Association of America. The institution of Dr. Okun has received research support from Michael J Fox. Dr. Okun has received publishing royalties from a publication relating to health care.
Patrick M. Grogan, MD, FAAN	No disclosure on file
Irene L. Katzan, MD	Dr. Katzan has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CSL Behring . The institution of Dr. Katzan has received research support from TEVA Pharmaceuticals.
David N. Herrmann, MD, FAAN	Dr. Herrmann has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acceleron. Dr. Herrmann has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Guidepoint global. Dr. Herrmann has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GLG. Dr. Herrmann has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurogene. Dr. Herrmann has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sarepta. Dr. Herrmann has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Regenacy. Dr. Herrmann has received intellectual property interests from a discovery or technology relating to health care.
Osama O. Zaidat, MD, FAAN	Dr. Zaidat has nothing to disclose.
Jawad F. Kirmani, MD	Dr. Kirmani has nothing to disclose.
Andreas R. Luft, MD	No disclosure on file
Katherine H. Noe, MD, PhD, FAAN	Dr. Noe has a non-compensated relationship as a committe member, Epilepsy MOC article review pilot with American Board of Psychiatry and Neurology that is relevant to AAN interests or activities.
Erika Driver-Dunckley, MD, FAAN	Dr. Driver-Dunckley has nothing to disclose.
Jeff Kraakevik, MD, FAAN	Dr. Kraakevik has stock in Multiple companies. The institution of Dr. Kraakevik has received research support from Parkinson Foundation. The institution of Dr. Kraakevik has received research support from Syngeric.
Ilya Kister, MD, FAAN	Dr. Kister has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech-Roche. Dr. Kister has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. The institution of Dr. Kister has received research support from Genentech. The institution of Dr. Kister has received research support from Novartis. Dr. Kister has received publishing royalties from a publication relating to health care.
Alberto J. Espay, MD, FAAN	Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Tanabe Pharma America (formerly, Neuroderm). Dr. Espay has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avion. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amneal. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Acadia. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Acorda. Dr. Espay has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kyowa Kirin. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sunovion. Dr. Espay has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Herantis Pharma. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Supernus (formerly USWorldMeds). Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Acadia. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Synaps Dx. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bial. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for NeuroDiagnostics, Inc (SYNAPS Dx). Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Intrance Medical Systems, Inc.. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merz. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Praxis Precision Medicines. Dr. Espay has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Citrus Health. Dr. Espay has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AskBio. The institution of Dr. Espay has received research support from NIH. The institution of Dr. Espay has received research support from Michael J Fox Foundation for Parkinson's Research. Dr. Espay has received intellectual property interests from a discovery or technology relating to health care. Dr. Espay has received publishing royalties from a publication relating to health care. Dr. Espay has received publishing royalties from a publication relating to health care. Dr. Espay has received publishing royalties from a publication relating to health care.
Michael Cartwright, MD	Dr. Cartwright has received publishing royalties from a publication relating to health care.
Lori A. Schuh, MD, FAAN	No disclosure on file
Majaz Moonis, MD, FAHA, FAAN	Dr. Moonis has nothing to disclose.
Richard S. Isaacson, MD, FAAN	Dr. Isaacson has stock in Retain Health. The institution of Dr. Isaacson has received research support from National Institutes of Health. The institution of Dr. Isaacson has received research support from Aces for Alzheimer's. The institution of Dr. Isaacson has received research support from BrainMind. Dr. Isaacson has received publishing royalties from a publication relating to health care.
Mark F. Lew, MD, FAAN	Dr. Lew has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Supernus. Dr. Lew has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for kyowa. Dr. Lew has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for neurocrine. Dr. Lew has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acorda. Dr. Lew has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acadia. Dr. Lew has received personal compensation in the range of $500-$4,999 for serving as a Consultant for RegenXBio. Dr. Lew has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Neurocrine. Dr. Lew has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Kyowa. Dr. Lew has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for acorda. The institution of Dr. Lew has received research support from MJFF. Dr. Lew has received research support from NIH.
Kenneth L. Marek, MD	Dr. Marek has received personal compensation for serving as an employee of IND. Dr. Marek has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for invicro. Dr. Marek has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Dr. Marek has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Marek has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biohaven. Dr. Marek has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for takeda. Dr. Marek has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Denali. Dr. Marek has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Koneksa. Dr. Marek has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Xingimaging. Dr. Marek has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neuron23. Dr. Marek has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lilly. Dr. Marek has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biohaven. Dr. Marek has received research support from Michael J Fox Foundation.
Roger M. Kurlan, MD, FAAN	No disclosure on file
Thanh Nguyen, MD	Dr. Nguyen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Vesalio. Dr. Nguyen has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for NIH. Dr. Nguyen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Avania. Dr. Nguyen has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AHA. The institution of Dr. Nguyen has received research support from Boston Medical Center. The institution of Dr. Nguyen has received research support from Society of Vascular and Interventional Neurology.
Violeta Diaz, MD	No disclosure on file
Nico J. Diederich, MD	No disclosure on file
Eric J. Sorenson, MD, FAAN	The institution of Dr. Sorenson has received research support from Biogen.
Jorge G. Burneo, MD, MSPH, FAAN	Dr. Burneo has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier, Clinical Neurology and Neurosurgery Journal. Dr. Burneo has received research support from The Jack Cowin Endowed Chair in Epilepsy Research. Dr. Burneo has received publishing royalties from a publication relating to health care. Dr. Burneo has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Jazz Pharmaceuticals.
Daniel D. Truong, MD, FAAN	The institution of Dr. Truong has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Supernus. The institution of Dr. Truong has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Amneal. The institution of Dr. Truong has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Neurocrine Biosciences. The institution of Dr. Truong has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Teva. The institution of Dr. Truong has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. The institution of Dr. Truong has received research support from Abbvie. The institution of Dr. Truong has received research support from Aeon. The institution of Dr. Truong has received research support from Biogen. The institution of Dr. Truong has received research support from Bukwang. The institution of Dr. Truong has received research support from Cerevel. The institution of Dr. Truong has received research support from Eli Lilly. The institution of Dr. Truong has received research support from Enterin. The institution of Dr. Truong has received research support from Ipsen. The institution of Dr. Truong has received research support from Lundbeck. The institution of Dr. Truong has received research support from Neurocrine. The institution of Dr. Truong has received research support from Neuroderm. The institution of Dr. Truong has received research support from Parkinson Foundation. The institution of Dr. Truong has received research support from Prilenia. The institution of Dr. Truong has received research support from Revance. The institution of Dr. Truong has received research support from Sunovion. Dr. Truong has received publishing royalties from a publication relating to health care. Dr. Truong has received publishing royalties from a publication relating to health care. Dr. Truong has a non-compensated relationship as a President with International Association for Parkinsonism and Related Disorders that is relevant to AAN interests or activities.
Jun Li, MD, PhD, FAAN	The institution of Dr. Li has received personal compensation in the range of $500-$4,999 for serving as a Consultant for FDA. The institution of Dr. Li has received research support from NIH. Dr. Li has a non-compensated relationship as a Associate Editor of ACTN journal with ANA that is relevant to AAN interests or activities.
Mirela Cerghet, MD, PhD, FAAN	Dr. Cerghet has nothing to disclose.
Minal Bhanushali, MD	Dr. Bhanushali has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lily. Dr. Bhanushali has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Eisai. Dr. Bhanushali has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Topline LLC. The institution of Dr. Bhanushali has received research support from Eli Lily.
Nuhad Abou Zeid, MD	No disclosure on file
James M. Stankiewicz, MD, FAAN	Dr. Stankiewicz has received personal compensation for serving as an employee of Novartis.
Carl Hoegerl, MD, FAAN	No disclosure on file
Shalom Haggiag, MD	No disclosure on file
Tsutomu Nakada, MD, PhD	No disclosure on file
Marwan N. Sabbagh, MD, FAAN	Dr. Sabbagh has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eisai. Dr. Sabbagh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genetech=Roche. Dr. Sabbagh has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novo Nordisk. Dr. Sabbagh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lilly. Dr. Sabbagh has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Synaptogenix. Dr. Sabbagh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Signant Health. Dr. Sabbagh has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Anavex. Dr. Sabbagh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cognito Therapeutics. Dr. Sabbagh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GSK. Dr. Sabbagh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Sabbagh has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for CervoMed. Dr. Sabbagh has stock in Neurotau. Dr. Sabbagh has stock in Seq Biomarque. Dr. Sabbagh has stock in uMethod Health. Dr. Sabbagh has stock in Athira. Dr. Sabbagh has stock in Lighthouse Pharmaceuticals. Dr. Sabbagh has stock in Alzheon. The institution of Dr. Sabbagh has received research support from NIH. The institution of Dr. Sabbagh has received research support from ADDF.
Gilles Defer, MD	Dr. Defer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Defer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen . Dr. Defer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis . Dr. Defer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche.
Mary Ganguli, MD, MPH	No disclosure on file
Hiroko H. Dodge, PhD	No disclosure on file
Anne L. Lafontaine, MD	Dr. Lafontaine has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Paladin. Dr. Lafontaine has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sunovion. Dr. Lafontaine has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbvie.
Jorge D. Correale, MD	Dr. Correale has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Correale has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Correale has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Correale has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Correale has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi-Genzyme. Dr. Correale has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ROche. Dr. Correale has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Correale has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Correale has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Correale has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi-Genzyme. The institution of Dr. Correale has received research support from Merck. The institution of Dr. Correale has received research support from Biogen. The institution of Dr. Correale has received research support from Novartis .
Adriano Chio, MD, FAAN	Dr. Chio has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cytokinetics. Dr. Chio has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi. Dr. Chio has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Chio has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Corcept.
Andrea Calvo, MD, PhD, FAAN	Dr. Calvo has nothing to disclose.
Orla Hardiman, MD, DSc, FRCPI, MRIA, FAAN	Dr. Hardiman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Wave Pharmaceuticals. Dr. Hardiman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cytokinetics . Dr. Hardiman has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Hardiman has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Taylor and Francis. The institution of Dr. Hardiman has received research support from Science Foundation Ireland. The institution of Dr. Hardiman has received research support from HRB.
Andrei G. Vlassenko, MD, PhD	No disclosure on file
Mark A. Mintun, MD	Dr. Mintun has received personal compensation for serving as an employee of Eli Lilly & Co.
Kleopas A. Kleopa, MD, FAAN	The institution of Dr. Kleopa has received research support from Sarepta Therapeutics. The institution of Dr. Kleopa has received research support from Neurogene Inc.
Kimiaki Utsugisawa, MD, PhD	Dr. Utsugisawa has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for argenx. Dr. Utsugisawa has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB pharma. Dr. Utsugisawa has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen pharma. Dr. Utsugisawa has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Viela Bio. Dr. Utsugisawa has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Chugai. Dr. Utsugisawa has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Mitsubisi Tanabe pharma. Dr. Utsugisawa has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Utsugisawa has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for argenx. Dr. Utsugisawa has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion phama. Dr. Utsugisawa has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Japan Blood Products Organization. Dr. Utsugisawa has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for UCB.
Yuriko Nagane, MD, PhD	No disclosure on file
Norihiro Suzuki	No disclosure on file
Shoji Tsuji, MD, PhD	The institution of Dr. Tsuji has received research support from Novelpharma Co. Ltd..
Ergun Y. Uc, MD	An immediate family member of Dr. Uc has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for American Board of Pediatrics. The institution of Dr. Uc has received research support from Department of Veterans Affairs. The institution of Dr. Uc has received research support from Department of Defense. The institution of an immediate family member of Dr. Uc has received research support from NIH. The institution of Dr. Uc has received research support from NIH. The institution of Dr. Uc has received research support from NIH. The institution of Dr. Uc has received research support from Parkinson's Foundation. The institution of Dr. Uc has received research support from NIH.
Jeffrey Dawson	Jeffrey Dawson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for iotaMotion. Jeffrey Dawson has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Congress of Neurological Surgeons. The institution of Jeffrey Dawson has received research support from Department of Veterans Affairs. The institution of Jeffrey Dawson has received research support from NIH.
Jianfeng Xiao	No disclosure on file
Alexis Elbaz, MD	No disclosure on file
Takayoshi Shimohata, MD, FAAN	Dr. Shimohata has nothing to disclose.
Rosana H. Scola, MD	Dr. Scola has nothing to disclose.
Lineu C. Werneck, MD	No disclosure on file
Helio Afonso G. Teive, MD, PhD, FAAN	Dr. Teive has nothing to disclose.
Paulo J. Lorenzoni, MD	Dr. Lorenzoni has nothing to disclose.
Takahiro Iizuka, MD	The institution of Dr. Iizuka has received research support from EUROIMMUN Japan Co., Ltd.
Saori Miyakawa	No disclosure on file
Junichi Hamada, MD, PhD	No disclosure on file
Key-Chung Park, MC	No disclosure on file
Mark J. Stillman, MD, FAAN	No disclosure on file
Brandon R. Grossardt, MS	No disclosure on file
James H. Bower, MD, MSc, FAAN	The institution of Dr. Bower has received research support from Abbvie.
Karen C. Albright, DO, DO, PhD, MS, MPH	Dr. Albright has nothing to disclose.
Alejandro A. Rabinstein, MD, FAAN	Dr. Rabinstein has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Boston Scientific. Dr. Rabinstein has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Shionogi . Dr. Rabinstein has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Chiesi. Dr. Rabinstein has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ceribell. Dr. Rabinstein has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurocritical care/NCS-Springer. Dr. Rabinstein has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wolters/UptoDate. Dr. Rabinstein has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for EBSCO/DynaMed. Dr. Rabinstein has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AHA. Dr. Rabinstein has received publishing royalties from a publication relating to health care. Dr. Rabinstein has received publishing royalties from a publication relating to health care. Dr. Rabinstein has received publishing royalties from a publication relating to health care. Dr. Rabinstein has received publishing royalties from a publication relating to health care.
Clementine Karageorgiou, MD	The institution of Dr. Karageorgiou has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for GENESIS PHARMA. The institution of Dr. Karageorgiou has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for TEVA-SPECIFAR.
Olivier Rouaud, MD	Dr. Rouaud has nothing to disclose.
Anthony Polazzo	No disclosure on file
Babak Boroojerdi, MD	Dr. Boroojerdi has received personal compensation for serving as an employee of UCB Biosciences. Dr. Boroojerdi has stock in UCB Biosciences.
Lara Jehi, MD	Dr. Jehi has nothing to disclose.
Lindsay A. Farrer, MD	No disclosure on file
Rivka Inzelberg, MD	No disclosure on file
Hen Hallevi, MD	No disclosure on file
James Dorman, MD, FAAN	Dr. Dorman has nothing to disclose.
Dawn Bowers, PhD	No disclosure on file
Oury Monchi, PhD	The institution of Dr. Monchi has received research support from Canadian Health Research Institutes. The institution of Dr. Monchi has received research support from National Science and Engineering and Research Council of Canada. The institution of Dr. Monchi has received research support from Brain Canada Parkinson Canada.
Maria P. Amato, PhD	Dr. Amato has received personal compensation for serving as an employee of AOUCareggi. Dr. Amato has received personal compensation for serving as an employee of AOUCareggi. Dr. Amato has received personal compensation for serving as an employee of AOUCareggi. Dr. Amato has received personal compensation for serving as an employee of AOU Careggi. Dr. Amato has received personal compensation for serving as an employee of AOUCareggi. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi Genzyme. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi genzyme. The institution of Dr. Amato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celgene BMS. The institution of Dr. Amato has received research support from Merck. The institution of Dr. Amato has received research support from Biogen. The institution of Dr. Amato has received research support from Roche.
Emilio Portaccio	Emilio Portaccio has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Emilio Portaccio has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck Serono. Emilio Portaccio has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Emilio Portaccio has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Emilio Portaccio has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Emilio Portaccio has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Biogen. Emilio Portaccio has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck Serono. Emilio Portaccio has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Emilio Portaccio has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Emilio Portaccio has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Janssen. Emilio Portaccio has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for BMS Cellgene.
Valentina Zipoli	No disclosure on file
Maria Bartolozzi	No disclosure on file
Maria Laura Stromillo, PhD	Maria Laura Stromillo, PhD has nothing to disclose.
Leonello Guidi, MD	No disclosure on file
Nicola De Stefano, MD	Dr. De Stefano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck Healthcare KGaA. Dr. De Stefano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunic AG. Dr. De Stefano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis Pharma AG. Dr. De Stefano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck Serono S.p.A. Dr. De Stefano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi Genzyme. Dr. De Stefano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche S.p.A.. The institution of Dr. De Stefano has received research support from Italian MS Society. The institution of Dr. De Stefano has received research support from Merck Healthcare KGaA.
Jaime Kulisevsky, MD, PhD	Dr. Kulisevsky has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Esteve. Dr. Kulisevsky has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Britannia. Dr. Kulisevsky has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AC Immune. Dr. Kulisevsky has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bial. Dr. Kulisevsky has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Zambon. Dr. Kulisevsky has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Britannia.
Javier Pagonabarraga	Javier Pagonabarraga has nothing to disclose.
Berta Maria Pascual Sedano	No disclosure on file
Gabriele Mora, MD	Dr. Mora has nothing to disclose.
Yuji Tanaka, MD, PhD	No disclosure on file
Cristina Moglia	Cristina Moglia has nothing to disclose.
Angelo Ghezzi, MD	No disclosure on file
Giancarlo Comi, MD	Dr. Comi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Janssen. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bristol Myers Squibb. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Aspen Healthcare. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Sanofi. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Rewind.
Tag-Eldin Sokrab, MD, PhD, FAAN	Dr. Sokrab has nothing to disclose.
Zhen Hong, MD	No disclosure on file
Ding Ding, MD, MPH	No disclosure on file
Amy R. Borenstein, PhD, FAAN	No disclosure on file
Jan Claassen, MD, PhD	Dr. Claassen has stock in iCE Neurosystems. The institution of Dr. Claassen has received research support from NINDS. The institution of Dr. Claassen has received research support from McDonnel Foundation. Dr. Claassen has received publishing royalties from a publication relating to health care. Dr. Claassen has received publishing royalties from a publication relating to health care.
Glen R. Finney, MD, FAAN	Dr. Finney has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Premier Inc. Dr. Finney has a non-compensated relationship as a Board Member with Greater Pennsylvania Chapter of the Alzheimer's Association that is relevant to AAN interests or activities.
Arshad Majid, MD	Dr. Majid has received publishing royalties from a publication relating to health care.
George A. Tagaris, MD	No disclosure on file
Bruce I. Ovbiagele, MD, MSc, FAAN	Dr. Ovbiagele has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Stroke Association. Dr. Ovbiagele has received research support from National Institutes of Health. Dr. Ovbiagele has a non-compensated relationship as a President with Society for Equity Neuroscience that is relevant to AAN interests or activities. Dr. Ovbiagele has a non-compensated relationship as a Board Member with World Stroke Organization that is relevant to AAN interests or activities.
Ramon L. Rodriguez Cruz, MD, FAAN	The institution of Dr. Rodriguez Cruz has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbvie. The institution of Dr. Rodriguez Cruz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Supernus . The institution of Dr. Rodriguez Cruz has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurocrine. The institution of Dr. Rodriguez Cruz has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Boston Scientific. The institution of Dr. Rodriguez Cruz has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbott. The institution of Dr. Rodriguez Cruz has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Acorda. The institution of Dr. Rodriguez Cruz has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Teva. The institution of Dr. Rodriguez Cruz has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Kyoway Kirin. The institution of Dr. Rodriguez Cruz has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Abbvie. The institution of Dr. Rodriguez Cruz has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Amneal. The institution of Dr. Rodriguez Cruz has received research support from Cerevance. The institution of Dr. Rodriguez Cruz has received research support from Neuraly. The institution of Dr. Rodriguez Cruz has received research support from Amneal. The institution of Dr. Rodriguez Cruz has received research support from Teva. The institution of Dr. Rodriguez Cruz has received research support from Neurocrine. Dr. Rodriguez Cruz has received publishing royalties from a publication relating to health care.
Web Ross, MD	The institution of Dr. Ross has received research support from Michael J Fox Foundation. The institution of Dr. Ross has received research support from NIH.
Howard Aizenstein, MD, PhD	No disclosure on file
Caterina Rosano, MD, MPH	No disclosure on file
Bennett L. Lavenstein, MD, FAAN	No disclosure on file
Paul W. O'Connor, MD	No disclosure on file
Ludwig Kappos, MD, FAAN	Dr. Kappos has nothing to disclose.
Masatoyo Nishizawa, MD	No disclosure on file
David P. Salmon, PhD	Dr. Salmon has nothing to disclose.
Ja-Seong Koo, MD	No disclosure on file
Jong-Moo Park, MD	No disclosure on file
Ohyun Kwon	No disclosure on file
Byung-kun Kim, MD	Dr. Kim has nothing to disclose.
Alexandros L. Georgiadis, MD	No disclosure on file
Muhammad F. Suri, MD	Dr. Suri has nothing to disclose.
Mustapha A. Ezzeddine, MD, FAAN	The institution of Dr. Ezzeddine has received research support from NIH.
Guillermo S. Garcia-Ramos, MD	No disclosure on file
Julie H. Carter	No disclosure on file
Andrew D. Siderowf, MD	Dr. Siderowf has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Siderowf has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi. Dr. Siderowf has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boehringer-Ingelheim. Dr. Siderowf has received personal compensation in the range of $500-$4,999 for serving as a Consultant for askbio. Dr. Siderowf has received personal compensation in the range of $500-$4,999 for serving as a Consultant for capsida. Dr. Siderowf has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Parkinson Study Group. Dr. Siderowf has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Theravance. Dr. Siderowf has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurocrine. Dr. Siderowf has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Prilenia. Dr. Siderowf has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Wave. Dr. Siderowf has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurogastrix. Dr. Siderowf has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Prevail. Dr. Siderowf has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alerity. Dr. Siderowf has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Clintrex. Dr. Siderowf has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Inhibikase. Dr. Siderowf has a non-compensated relationship as a Scientific Advisory Board with NeuroPacs that is relevant to AAN interests or activities.
Francisco De Assis Gondim, MD, PhD, MSc, FAAN	No disclosure on file
Iscia Lopes-Cendes, MD, PhD	No disclosure on file
John D. Schwankhaus, MD	No disclosure on file
W. S. Metzer, MD, FAAN	No disclosure on file
Michael L. Reed, PhD	The institution of Dr. Reed has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Eli Lilly. The institution of Dr. Reed has received research support from Allergan. The institution of Dr. Reed has received research support from Dr Reddy's Labs/Promius. The institution of Dr. Reed has received research support from Allay Lamp. Dr. Reed has a non-compensated relationship as a Research Analyst with National Headache Foundation that is relevant to AAN interests or activities.
Holly A. Shill, MD, FAAN	Dr. Shill has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sage Biogen. Dr. Shill has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Shill has received personal compensation in the range of $500-$4,999 for serving as a Consultant for KeifeRx. Dr. Shill has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Praxis Precision Medicine. Dr. Shill has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Fasikl Inc. Dr. Shill has received personal compensation in the range of $0-$499 for serving as a Consultant for Boston Scientific. Dr. Shill has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi Tanabe Pharma America.
Nizar Souayah, MD, FAAN	Dr. Souayah has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Takeda. Dr. Souayah has received publishing royalties from a publication relating to health care.
Carlos Costa	No disclosure on file
Joseph Hentz	No disclosure on file
Jonathan M. Goldstein, MD	No disclosure on file
Kenshi Terajima, MD, PhD	No disclosure on file
Robert J. Ivnik, PhD	No disclosure on file
Thomas Beach	Thomas Beach has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vivid Genomics. Thomas Beach has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche Diagnostics. The institution of Thomas Beach has received research support from National Institutes of Health. The institution of Thomas Beach has received research support from Michael J Fox Foundation . The institution of Thomas Beach has received research support from State of Arizona.
Afshin A. Divani, PhD	The institution of Dr. Divani has received research support from Department of Defense.
Edgardo Cristiano, MD	Dr. Cristiano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Cristiano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Cristiano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Genzyme. Dr. Cristiano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Cristiano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck.
Ulrich Bogdahn, MD	No disclosure on file
Ludwig Aigner, PhD	No disclosure on file
Kallol R. Chaudhuri, MD, FRCP	Dr. Chaudhuri has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbvie, Acadia, GSK, Scion, Britannia , Lobsor. Dr. Chaudhuri has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie, Britannia, Scion, Sunovion, UCB, . Dr. Chaudhuri has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie, Britannia, UCB, Zambon. Dr. Chaudhuri has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for NPJ PD journal. The institution of Dr. Chaudhuri has received research support from Britania Pharmaceuticals, AbbVie, UCB, GKC, Bial, Aacdemic grants: EU, IMI EU, Horizon 2020, Parkinson's UK, NIHR, PDNMG, EU (Horizon 2020), Kirby Laing Foundation, NPF, MRC, Wellcome Trust.
Matthew Greenway, MD	No disclosure on file
Antonio Bertolotto, MD, FAAN	Dr. Bertolotto has nothing to disclose.
Marco Capobianco, MD	No disclosure on file
Simona Malucchi	No disclosure on file
Alessia Di Sapio, MD	No disclosure on file
Joseph Herbert, MD	No disclosure on file
Teresa M. Mangin, MD, FAAN	Dr. Mangin has nothing to disclose.
Helen Petrovitch, MD	No disclosure on file
Angela Vincent, MBBS, MSc	Angela Vincent, MBBS, MSc has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Lundbeck Foundation. Angela Vincent, MBBS, MSc has received intellectual property interests from a discovery or technology relating to health care.
Gloria Von Geldern, MD, FAAN	The institution of Dr. Von Geldern has received research support from Novartis. The institution of Dr. Von Geldern has received research support from Contineum Therapeutics. Dr. Von Geldern has received personal compensation in the range of $0-$499 for serving as a DSMB member with NIH, NINDS. Dr. Von Geldern has a non-compensated relationship as a editorial board member with MS and Related Disorders Journal that is relevant to AAN interests or activities.
Francisco J. Carod-Artal, MD, FAAN	Dr. Carod-Artal has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Meyers. Dr. Carod-Artal has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bial. Dr. Carod-Artal has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for GW. Dr. Carod-Artal has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Carod-Artal has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck Serono. Dr. Carod-Artal has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Novartis. Dr. Carod-Artal has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bristol Meyers Squip. Dr. Carod-Artal has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Merz. Dr. Carod-Artal has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Ipsen. Dr. Carod-Artal has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Janssen.
Vannina Pieri	No disclosure on file
Abelardo Q. Araujo, MD, PhD, MSc	No disclosure on file
Eduard Linetsky, MD	No disclosure on file
Stephan Zuchner, MD, FAAN	Dr. Zuchner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Applied Therapeutics. The institution of Dr. Zuchner has received research support from Muscular Dystrophy Association. The institution of Dr. Zuchner has received research support from CMT Association. Dr. Zuchner has received intellectual property interests from a discovery or technology relating to health care.
Minas Tzagournissakis, MD	No disclosure on file
Andreas J. Plaitakis, MD	No disclosure on file
Steven W. Anderson, PhD	Dr. Anderson has nothing to disclose.
Carlos A. Pardo-Villamizar, MD	The institution of Dr. Pardo-Villamizar has received research support from National Institutes of Health. The institution of Dr. Pardo-Villamizar has received research support from Bart McLean Fund for Neuroimmunology Research .
Agnieszka Slowik, MD, FAAN	Dr. Slowik has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Boehringer, . Dr. Slowik has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Slowik has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis.
Barbara Tomik, MD, PhD	No disclosure on file
Julie Phukan, MB, BCh, MRCPI	No disclosure on file
Antonio Giorgio, MD	Dr. Giorgio has nothing to disclose.
Peter Rieckmann, MD, FAAN	No disclosure on file
Lindsey E. Kirsch Darrow	No disclosure on file
Claudia Trenkwalder, MD	Dr. Trenkwalder has received personal compensation for serving as an employee of Paracelsus-Kliniken. Dr. Trenkwalder has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Trenkwalder has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Trenkwalder has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Trenkwalder has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bial. Dr. Trenkwalder has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Trenkwalder has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Esteve. Dr. Trenkwalder has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Convatec. Dr. Trenkwalder has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boehringer. Dr. Trenkwalder has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. The institution of Dr. Trenkwalder has received research support from DLR /BMBF. Dr. Trenkwalder has received intellectual property interests from a discovery or technology relating to health care.
Andrew Tarulli, MD	No disclosure on file
John M. Stern, MD, FAAN	Dr. Stern has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB Pharma. Dr. Stern has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for SK Life Science. Dr. Stern has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neurelis. Dr. Stern has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Ceribell. Dr. Stern has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Jazz Pharma. Dr. Stern has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for LivaNova. Dr. Stern has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Neurelis. Dr. Stern has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for LivaNova. Dr. Stern has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Sunovion. Dr. Stern has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Jazz. Dr. Stern has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for SK Life Sciences. Dr. Stern has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MedLink Neurology. Dr. Stern has stock in DEARhealth. Dr. Stern has stock in Ceribell. Dr. Stern has received publishing royalties from a publication relating to health care. Dr. Stern has received publishing royalties from a publication relating to health care. Dr. Stern has received publishing royalties from a publication relating to health care. Dr. Stern has received publishing royalties from a publication relating to health care.
John G. Whitesides	John G. Whitesides has received personal compensation for serving as an employee of UCB. John G. Whitesides has received stock or an ownership interest from UCB.
Douglas Woo, MD	No disclosure on file
Steven J. Greenberg, MD	No disclosure on file
Per Solberg Sorensen, MD, PhD, FAAN	Dr. Sorensen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Sorensen has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Sorensen has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Sorensen has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TEVA.
Scott L. Silliman, MD	Dr. Silliman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech.
Guy M. McKhann, MD	No disclosure on file
David G. Munoz, MD	No disclosure on file
Madhuri Behari, MD	No disclosure on file
Sumit Singh, MD	No disclosure on file
Daniel L. Labovitz, MD	An immediate family member of Dr. Labovitz has received personal compensation for serving as an employee of Herrick Feinstein.
Vasileios Mastorodemos, MD	No disclosure on file
Cleanthe Spanaki, MD, PhD	The institution of Dr. Spanaki has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PHARMABIDE/SPECIFAR-TEVA. The institution of Dr. Spanaki has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ALLERGAN. The institution of Dr. Spanaki has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. The institution of Dr. Spanaki has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MERCK SERONO. The institution of Dr. Spanaki has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for ITF. The institution of Dr. Spanaki has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for SPECIFAR/TEVA. The institution of Dr. Spanaki has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for ABBVIE. The institution of Dr. Spanaki has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for ABBVIE. The institution of Dr. Spanaki has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for SPECIFAR/TEVA. The institution of Dr. Spanaki has received research support from ABBVIE.
Michael McDermott	No disclosure on file
Joanne Wuu, SCM	The institution of Ms. Wuu has received research support from NIH NINDS. The institution of Ms. Wuu has received research support from NIH NCATS/NINDS. The institution of Ms. Wuu has received research support from CDC. The institution of Ms. Wuu has received research support from Target ALS. The institution of Ms. Wuu has received research support from ALS Recovery Fund. The institution of Ms. Wuu has received research support from NIH/NINDS. The institution of Ms. Wuu has received research support from NIH NINDS. The institution of an immediate family member of Ms. Wuu has received research support from NIH NINDS.
Anabel R. Chade, MD	No disclosure on file
Raul L. Arizaga, MD, FAAN	No disclosure on file
Carole Dufouil, PhD	No disclosure on file
Christophe Tzourio, MD, PhD	No disclosure on file
Sue M. Lai, PhD	No disclosure on file
Liliana B. Patrucco, MD	Dr. Patrucco has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Dr. Patrucco has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Patrucco has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Novartis. Dr. Patrucco has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Biogen.
Aparna Wagle-Shukla, MD, FAAN	Dr. Wagle-Shukla has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Encora. Dr. Wagle-Shukla has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Supernus. Dr. Wagle-Shukla has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for Tremor research group. The institution of Dr. Wagle-Shukla has received research support from NIH. Dr. Wagle-Shukla has received personal compensation in the range of $500-$4,999 for serving as a reviewer with NIH.
Yousef Mohammad, MD	No disclosure on file
Ophelia Godin	No disclosure on file
Nabila Dahodwala, MD, FAAN	Dr. Dahodwala has received personal compensation in the range of $0-$499 for serving as a Consultant for Genentech. Dr. Dahodwala has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mediflix. Dr. Dahodwala has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Acadia. Dr. Dahodwala has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Post and Schell. Dr. Dahodwala has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for O'Brien & Ryan, LLP. Dr. Dahodwala has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for MotleyRice. The institution of Dr. Dahodwala has received research support from AbbVie. The institution of Dr. Dahodwala has received research support from Medtronic.
A. D. Rothner, MD	No disclosure on file
Roger L. Albin, MD	Dr. Albin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda. Dr. Albin has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Albin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biohaven. Dr. Albin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Vaccinex. The institution of Dr. Albin has received research support from NIH-NINDS. The institution of Dr. Albin has received research support from Parkinson's Foundation. The institution of Dr. Albin has received research support from Michael J. Fox Foundation. Dr. Albin has received personal compensation in the range of $5,000-$9,999 for serving as a Grant Application Reivewer with Michael J. Fox Foundation.
Deborah M. Miller, PhD	Dr. Miller has received intellectual property interests from a discovery or technology relating to health care.
Warren W. Barker, MA	No disclosure on file
Karla P. Figueroa	Ms. Figueroa has nothing to disclose.
Joan M. Ohayon	Joan M. Ohayon has nothing to disclose.
Maryann Mays, MD, FAAN	Dr. Mays has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Dr. Mays has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Oakley Health. Dr. Mays has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CoolTech Medical. Dr. Mays has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Abbvie. Dr. Mays has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Dynamed. The institution of Dr. Mays has received research support from Amgen. The institution of Dr. Mays has received research support from Lundbeck.
Jeffrey C. Wagner, MD	Dr. Wagner has nothing to disclose.
Jeffrey Politsky, MD, FRCP(c)	No disclosure on file
Lumine Matsumoto, MD, PhD	No disclosure on file
Stephen N. Scelsa, MD	No disclosure on file
Thomas J. Wolfe, MD	No disclosure on file
Kwok-Keung Tai	No disclosure on file
Timothy E. Lotze, MD, FAAN	Dr. Lotze has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Department of Justice VICP. The institution of Dr. Lotze has received research support from NIH. The institution of Dr. Lotze has received research support from National MS Society. The institution of Dr. Lotze has received research support from Sarepta Therapeutics. The institution of Dr. Lotze has received research support from PTC THERAPEUTICS. The institution of Dr. Lotze has received research support from Avexis. Dr. Lotze has received publishing royalties from a publication relating to health care. Dr. Lotze has received publishing royalties from a publication relating to health care.
Jayashri Srinivasan, MD, PhD, MRCP, FAAN	Dr. Srinivasan has nothing to disclose.
Ranjan Duara, MD	Dr. Duara has nothing to disclose.
Lon R. White, MD	No disclosure on file
Robert D. Abbott, PhD	No disclosure on file
Pooja Khatri, MD, FAAN	The institution of Dr. Khatri has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lumosa. Dr. Khatri has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Bayer. The institution of Dr. Khatri has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Diamedica. Dr. Khatri has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Basking Biosciences. Dr. Khatri has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Heart Association. The institution of Dr. Khatri has received research support from Cerenovus. Dr. Khatri has received publishing royalties from a publication relating to health care.
Kathleen Alwell	No disclosure on file
Matthew L. Flaherty, MD	Dr. Flaherty has received personal compensation for serving as an employee of Sense Diagnostics, Inc. Dr. Flaherty has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boeringher Engelheim. Dr. Flaherty has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for CSL Behring. Dr. Flaherty has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Alexion. Dr. Flaherty has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for various law firms. Dr. Flaherty has stock in Sense Diagnostics, Inc. The institution of Dr. Flaherty has received research support from NINDS. Dr. Flaherty has received intellectual property interests from a discovery or technology relating to health care.
Manuel M. Buitrago Blanco, MD, PhD	No disclosure on file
Sean I. Savitz, MD	Dr. Savitz has nothing to disclose.
James A. Mortimer, PhD, FAAN	No disclosure on file
Ken Uchino, MD	Dr. Uchino has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Aboott Laboratories, Inc.. Dr. Uchino has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for ACP JOURNAL CLUB. The institution of Dr. Uchino has received research support from NIH.
Nicolaas I. Bohnen, MD, PhD, FAAN	Dr. Bohnen has stock in Delta. The institution of Dr. Bohnen has received research support from NIH. The institution of Dr. Bohnen has received research support from VA. Dr. Bohnen has received research support from NIH. The institution of Dr. Bohnen has received research support from Parkinson fnd.
A. M. Barrett, MD, FAAN	The institution of Dr. Barrett has received research support from Veterans Health Association. The institution of Dr. Barrett has received research support from National Institutes of Health. The institution of Dr. Barrett has received research support from Mabel H Flory Trust. Dr. Barrett has received personal compensation in the range of $0-$499 for serving as a author, chapter with WebMD. Dr. Barrett has received personal compensation in the range of $10,000-$49,999 for serving as a scientific advisor with Winifred Masterson Burke Foundation.
Ahmad M. Al-Sabbagh, MD	Dr. Al-Sabbagh has nothing to disclose.
Randy Bennett	No disclosure on file
Roi A. Wallis, MD	No disclosure on file
Robert A. Taylor, MD	No disclosure on file
Huned S. Patwa, MD, FAAN	No disclosure on file
David E. Thaler, MD, PhD, FAAN	Dr. Thaler has nothing to disclose.
Leonard van den Berg, MD	The institution of Dr. Van den Berg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amylyx. The institution of Dr. Van den Berg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ferrrer. The institution of Dr. Van den Berg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. The institution of Dr. Van den Berg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. The institution of Dr. Van den Berg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Takeda. The institution of Dr. Van den Berg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Van den Berg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS. The institution of Dr. Van den Berg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ArgenX. The institution of Dr. Van den Berg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Projenx. Dr. Van den Berg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Corcept. The institution of Dr. Van den Berg has received research support from Netherlands ALS Foundation.
John P. Seibyl, MD	Dr. Seibyl has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Invicro. Dr. Seibyl has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Seibyl has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Life Molecular Imaging. Dr. Seibyl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Dr. Seibyl has received stock or an ownership interest from Invicro.
David S. Glosser, ScD	No disclosure on file
Magnhild Sandberg-Wollheim, MD, PhD	No disclosure on file
Jacqueline Beagan, BSN	No disclosure on file
Lyell K. Jones, MD, FAAN	Dr. Jones has received personal compensation in the range of $100,000-$499,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for ��ɫ��. Dr. Jones has received publishing royalties from a publication relating to health care. Dr. Jones has received personal compensation in the range of $10,000-$49,999 for serving as a President-Elect with ��ɫ��. Dr. Jones has a non-compensated relationship as a member of the AAN Board of Directors with AAN that is relevant to AAN interests or activities. Dr. Jones has a non-compensated relationship as a Chair of the Mayo Clinic ACO Board of Directors with Mayo Clinic that is relevant to AAN interests or activities.
Gary A. Stobbe, MD	No disclosure on file
Gustavo J. Rodriguez, MD	Dr. Rodriguez has nothing to disclose.
Diane S. Book, MD	No disclosure on file
Yoshio Tsuboi, MD	Dr. Tsuboi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eisai Co., Ltd.,. Dr. Tsuboi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Takeda Pharmaceutical Co., Ltd.,. Dr. Tsuboi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sumitomo Dainippon Pharma Co., Ltd.. Dr. Tsuboi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AbbVie GK,. Dr. Tsuboi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Otsuka Pharmaceutical Co., Ltd.. Dr. Tsuboi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kyowa Kirin Co., Ltd.. The institution of Dr. Tsuboi has received research support from Nipro Corporation.
H. R. Jones, Jr., MD	No disclosure on file
Ana C. Leite, MD	No disclosure on file
Irene Malaty, MD, FAAN	Dr. Malaty has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. Dr. Malaty has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Aevum. The institution of Dr. Malaty has received research support from Abbvie. The institution of Dr. Malaty has received research support from Revance. The institution of Dr. Malaty has received research support from Parkinson Foundation. The institution of Dr. Malaty has received research support from SAGE. The institution of Dr. Malaty has received research support from Emalex. The institution of Dr. Malaty has received research support from Acadia. Dr. Malaty has received publishing royalties from a publication relating to health care. Dr. Malaty has received personal compensation in the range of $500-$4,999 for serving as a Speaker & Center of Excellence Director with Parkinson Foundation. Dr. Malaty has a non-compensated relationship as a MAB member & Center of Excellence Directory with Tourette Association of America that is relevant to AAN interests or activities.
Jayne Ness, MD	An immediate family member of Dr. Ness has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jan One. The institution of Dr. Ness has received research support from Chugai/Roche. The institution of Dr. Ness has received research support from National Multiple Sclerosis Society. The institution of an immediate family member of Dr. Ness has received research support from NIH. An immediate family member of Dr. Ness has received publishing royalties from a publication relating to health care.
Ejaz Shamim, MD, MS, MBA, FAAN	The institution of Dr. Shamim has received research support from Michael J. Fox Foundation.
John H. Sladky, MD, FAAN	Dr. Sladky has nothing to disclose.
Barbara C. Jobst, MD, PhD, FAAN	Dr. Jobst has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN. The institution of Dr. Jobst has received research support from Neuropace, Inc.. The institution of Dr. Jobst has received research support from NIH. The institution of Dr. Jobst has received research support from CDC.
Kenneth J. Gaines, MD	No disclosure on file
Autumn Klein, MD, PhD	No disclosure on file
Kate Bushby, MD	Dr. Bushby has nothing to disclose.
Sylvain Chouinard, MD	No disclosure on file
Mandar S. Jog, MD, FAAN	Dr. Jog has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merz. Dr. Jog has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. Dr. Jog has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Ipsen. Dr. Jog has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Abbvie. Dr. Jog has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Ipsen. Dr. Jog has stock in MDDT .
Fay B. Horak, PhD	No disclosure on file
Kelvin L. Chou, MD, FAAN	Dr. Chou has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Accordant. Dr. Chou has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neurocrine. Dr. Chou has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbott. Dr. Chou has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cerevance. Dr. Chou has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Advarra. The institution of Dr. Chou has received research support from NIH. The institution of Dr. Chou has received research support from Parkinson Study Group. The institution of Dr. Chou has received research support from Michael J Fox Foundation. The institution of Dr. Chou has received research support from Cerevance. Dr. Chou has received publishing royalties from a publication relating to health care. Dr. Chou has received publishing royalties from a publication relating to health care.
Maria V. Alvarez, MD	No disclosure on file
Vera Bril, MD	Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CSL. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alnylam. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Grifols. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Octapharma. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Powell Mansfield. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Akcea. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ionis. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunovant. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Momenta (now J&J). Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NovoNordisk. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Takeda. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunovant. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Bril has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Akcea. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alnylam. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CSL. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. The institution of Dr. Bril has received research support from UCB. The institution of Dr. Bril has received research support from Argenx. The institution of Dr. Bril has received research support from Momenta (now J&J). The institution of Dr. Bril has received research support from Immunovant. The institution of Dr. Bril has received research support from Alexion. The institution of Dr. Bril has received research support from Takeda. The institution of Dr. Bril has received research support from Grifols. The institution of Dr. Bril has received research support from CSL. The institution of Dr. Bril has received research support from Octapharma. The institution of Dr. Bril has received research support from Akcea. The institution of Dr. Bril has received research support from Ionis. The institution of Dr. Bril has received research support from Viela Bio (now Horizon). Dr. Bril has received intellectual property interests from a discovery or technology relating to health care.
Michael G. Benatar, MBChB, DPhil, FAAN	Dr. Benatar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. The institution of Dr. Benatar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Arrowhead. Dr. Benatar has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alexion. Dr. Benatar has received personal compensation in the range of $0-$499 for serving as a Consultant for Annexon. Dr. Benatar has received personal compensation in the range of $0-$499 for serving as a Consultant for UniQure. Dr. Benatar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunovant. Dr. Benatar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cartesian. Dr. Benatar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Horizon. Dr. Benatar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Benatar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. Dr. Benatar has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for CorEvitas. Dr. Benatar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Canopy. Dr. Benatar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alaunos. Dr. Benatar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Prilenia. Dr. Benatar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Benatar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alector. Dr. Benatar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Benatar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for BMS. Dr. Benatar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Woolsey. Dr. Benatar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda. Dr. Benatar has received intellectual property interests from a discovery or technology relating to health care.
Rakesh Khatri, MD, FAAN	Dr. Khatri has received personal compensation in the range of $0-$499 for serving as a Survey consultant with Alpha insight . Dr. Khatri has received personal compensation in the range of $0-$499 for serving as a Survey consultant with Survey company .
Jie-Yuan Li, MD	No disclosure on file
Simon Cronin, PhD	Prof. Cronin has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis.
Alexandre Gironell, MD	No disclosure on file
Alexander Lossos, MD	Dr. Lossos has nothing to disclose.
Gordon T. Plant	No disclosure on file
John E. Duda, MD	Dr. Duda has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Nature Publishing Group. The institution of Dr. Duda has received research support from Department of Veterans Affairs. The institution of Dr. Duda has received research support from Michael J. Fox Foundation. The institution of Dr. Duda has received research support from Innervace, Incorporated. The institution of Dr. Duda has received research support from National Institutes of Health.
Bryan Traynor, MD	The institution of Dr. Traynor has received research support from ALS Association. The institution of Dr. Traynor has received research support from Merck. The institution of Dr. Traynor has received research support from Myasthenia Gravis Foundation. The institution of Dr. Traynor has received research support from Cerevel Therapeutics. Dr. Traynor has received intellectual property interests from a discovery or technology relating to health care.
Amy Pace, ScD	No disclosure on file
P. D. Charles, MD, FAAN	Dr. Charles has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Revance. Dr. Charles has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Iota. Dr. Charles has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kyowa Kirin. Dr. Charles has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ceraxis. Dr. Charles has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Aspen Neuroscience. Dr. Charles has stock in Arena Therapeutics. The institution of Dr. Charles has received research support from Pharma 2 B. The institution of Dr. Charles has received research support from Intec. The institution of Dr. Charles has received research support from Merz. The institution of Dr. Charles has received research support from Novartis. The institution of Dr. Charles has received research support from Aeon. The institution of Dr. Charles has received research support from Impax. The institution of Dr. Charles has received research support from AskBio. The institution of Dr. Charles has received research support from BlueRock. The institution of Dr. Charles has received research support from AbbVie. The institution of Dr. Charles has received research support from Ipsen.
Helmut Butzkueven, MD, MBBS	Dr. Butzkueven has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Oxford Health Policy Forum. The institution of Dr. Butzkueven has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. The institution of Dr. Butzkueven has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merck. The institution of Dr. Butzkueven has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. The institution of Dr. Butzkueven has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Dr. Butzkueven has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for MSBase . The institution of Dr. Butzkueven has received research support from NHMRC. The institution of Dr. Butzkueven has received research support from Biogen. The institution of Dr. Butzkueven has received research support from Roche. The institution of Dr. Butzkueven has received research support from Novartis.
Maria Trojano	Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi_Genzyme. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sandoz. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi-Genzyme. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Janssen.
Anand Trip, MD	No disclosure on file
Amie W. Hsia, MD	The institution of Dr. Hsia has received research support from NIH/NINDS.
Andrew Singleton	An immediate family member of Andrew Singleton has received personal compensation for serving as an employee of GeneDx. Andrew Singleton has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Nature Partner Journals Parkinson Disease. Andrew Singleton has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Movement Disorders Journal. An immediate family member of Andrew Singleton has stock in GeneDx. The institution of Andrew Singleton has received research support from Michael J Fox Foundation. Andrew Singleton has received intellectual property interests from a discovery or technology relating to health care. Andrew Singleton has received intellectual property interests from a discovery or technology relating to health care.
Vicente J. Iragui-Madoz, MD, PhD	No disclosure on file
Carmen Bozic, MD	No disclosure on file
Adriana A. Kori, MD	No disclosure on file
Mitchell F. Brin, MD, FAAN	Dr. Brin has received personal compensation for serving as an employee of Allergan. Dr. Brin has stock in Allergan.
Annapurni J. Trouth, MD, FAAN	No disclosure on file
Kevin M. Biglan, MD	Dr. Biglan has received personal compensation for serving as an employee of Eli Lilly. Dr. Biglan has received stock or an ownership interest from Eli Lilly.
Anand Vaishnav, MD	No disclosure on file
Dhruvil J. Pandya, MD	No disclosure on file
Jyoti Pillai, MD, MBBS, MRCP, FAAN, FAAN	Dr. Pillai has a non-compensated relationship as a President with Pennsylvania Neurological Association that is relevant to AAN interests or activities.
E. Ray Dorsey, MD, MBA	Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Seelos Therapeutics. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eden McCallum, LLP. Dr. Dorsey has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech/Roche. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biohaven Pharmaceuticals. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for WebMD. Dr. Dorsey has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for BioSensics. Dr. Dorsey has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Mediflix. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cerevance. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kairos Cinema, LLC. Dr. Dorsey has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Mitsubishi Tanabe Pharma America Inc.. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for HanAll. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Dorsey has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Advarra. Dr. Dorsey has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medrhythms. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for ANA. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for HMP ��ɫ��, LLP. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for ADIVO Associates France. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for University of Toronto. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Philadelphia Neurological Society. Dr. Dorsey has stock in Included Health. Dr. Dorsey has stock in Mediflix. Dr. Dorsey has stock in SemCap. Dr. Dorsey has stock in Synapticure. The institution of Dr. Dorsey has received research support from NIH/NINDS. The institution of Dr. Dorsey has received research support from Burroughs Wellcome . The institution of Dr. Dorsey has received research support from Michael J. Fox Foundation - Fox Insight. The institution of Dr. Dorsey has received research support from Michael J. Fox Foundation - Emerald. The institution of Dr. Dorsey has received research support from B. Thomas Golisano Foundation. The institution of Dr. Dorsey has received research support from Emerald Innovations, Inc.. The institution of Dr. Dorsey has received research support from Photopharmics Inc.. The institution of Dr. Dorsey has received research support from Averitas Pharma Inc.. The institution of Dr. Dorsey has received research support from DOD/Army Medical Research Acquisition Activity. The institution of Dr. Dorsey has received research support from NIH/NINDS.
Carlos S. Kase, MD, FAHA, FAAN	Dr. Kase has nothing to disclose.
Michael I. Shevell, MD, FAAN	Dr. Shevell has nothing to disclose.
Alessandro Di Rocco, MD	Dr. Di Rocco has nothing to disclose.
Manuel Seijo-Martinez, MD, PhD, FAAN	No disclosure on file
Man Mohan Mehndiratta, MD, MBBS, FAAN	Dr. Mehndiratta has nothing to disclose.
Steven Edland, MS	No disclosure on file
Freya Kamel, PhD	No disclosure on file
Mohammad Wasay, MBBS, FAAN	Dr. Wasay has nothing to disclose.
Fiona M. Molloy, MD	Dr. Molloy has nothing to disclose.
Subhash Kaul, MD, DM, FAAN	No disclosure on file
Robin A. Elliott	No disclosure on file
Mefkure Eraksoy, MD	Dr. Eraksoy has nothing to disclose.
Debabrata Ghosh, MD	No disclosure on file
Heinz Wiendl, MD, FAAN	Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunovant. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Johnson&Johnson / Janssen. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Wiendl has received personal compensation in the range of $0-$499 for serving as a Consultant for Idorsia. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Argenx. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Immunic. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for LTS. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Samsung. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sangamo. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dianthus. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for INmune Bio_Syneos Health. Dr. Wiendl has received personal compensation in the range of $0-$499 for serving as a Consultant for Muna Therapeutics. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Myrobalan Therapeutics. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PSL Group. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Red Nucleus. Dr. Wiendl has received personal compensation in the range of $0-$499 for serving as a Consultant for Swiss Multiple Sclerosis Society. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Teladoc Health. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Toleranzia . Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Viatris. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck Serono. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squibb. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sandoz. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sandoz-Hexal. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cellerys. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Uniqure. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biocryst. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Galapagos. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Idorsia. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biontech. The institution of Dr. Wiendl has received research support from Biogen. The institution of Dr. Wiendl has received research support from Roche. The institution of Dr. Wiendl has received research support from Deutsche Forschungsgemeinschaft. The institution of Dr. Wiendl has received research support from European Union. The institution of Dr. Wiendl has received research support from Argenx. The institution of Dr. Wiendl has received research support from CSL Behring. The institution of Dr. Wiendl has received research support from Merck. The institution of Dr. Wiendl has received research support from UCB. Dr. Wiendl has received research support from Alexion Syneos Health iVH UK Ltd.. The institution of Dr. Wiendl has received research support from Deutsche Myasthenie-Gesellschaft. The institution of Dr. Wiendl has received research support from Winicker Norimed GmbH. The institution of Dr. Wiendl has received research support from Novartis. Dr. Wiendl has received publishing royalties from a publication relating to health care. Dr. Wiendl has received publishing royalties from a publication relating to health care. Dr. Wiendl has received publishing royalties from a publication relating to health care.
Kiwon Lee, MD	No disclosure on file
Stephanie Lessig, MD	No disclosure on file
Marilou I. Ching, MD	Dr. Ching has nothing to disclose.
Hideki Mochizuki, MD	No disclosure on file
Kathleen M. Zackowski, PhD, OTR	Dr. Zackowski has received personal compensation for serving as an employee of National MS Society.
Yuko Palesch	No disclosure on file
Jean-Francois Gagnon	The institution of Jean-Francois Gagnon has received research support from Canadian Institute of Health Research. The institution of Jean-Francois Gagnon has received research support from Canada Research Chair. The institution of Jean-Francois Gagnon has received research support from National Institutes of Health.
Rebecca Spain, MD, MSPH, FAAN	Dr. Spain has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for United States Department of Justice. The institution of Dr. Spain has received research support from Department of Veterans Affairs. The institution of Dr. Spain has received research support from National Multiple Sclerosis Society.
Andrew Henderson, MD	Dr. Henderson has nothing to disclose.
Aleksandra Pikula, MD	The institution of Dr. Pikula has received research support from CIHR.
Yannie O. Soo, MD	No disclosure on file
Alfredo Damasceno, MD	No disclosure on file
Carla Stefani, MD	No disclosure on file
Mouhammad A. Jumaa, MD	Dr. Jumaa has nothing to disclose.
Gonzalo Revuelta, DO	The institution of Dr. Revuelta has received research support from NIH.
Indrani Acosta, MD	No disclosure on file
Prem Kandiah, MD	Dr. Kandiah has nothing to disclose.
Daniel O. Claassen, MD, FAAN	Dr. Claassen has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Alterity. Dr. Claassen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. Dr. Claassen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. Dr. Claassen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AskBio. Dr. Claassen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for University of Michigan. Dr. Claassen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cognition Therapeutics . Dr. Claassen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amylyx. The institution of Dr. Claassen has received research support from NIH. The institution of Dr. Claassen has received research support from CHDI. The institution of Dr. Claassen has received research support from HDSA. The institution of Dr. Claassen has received research support from Department of Defense. The institution of Dr. Claassen has received research support from CHDI.
Opeolu Adeoye	No disclosure on file
Tariq M. Aziz	No disclosure on file
Daniel J. Berlau, PhD	No disclosure on file
Kandan Kulandaivel, MD	No disclosure on file
Maria T. Greig Custo	No disclosure on file
Atsushi Iwata, MD	No disclosure on file
David Irwin, MD	The institution of Dr. Irwin has received research support from NIH. The institution of Dr. Irwin has received research support from Prevail. The institution of Dr. Irwin has received research support from Passage Bio. The institution of Dr. Irwin has received research support from Alector. The institution of Dr. Irwin has received research support from Transposon. The institution of Dr. Irwin has received research support from Denali. The institution of Dr. Irwin has received research support from Cervo Med.
Nilufer Kale Icen, MD	Dr. Kale has nothing to disclose.
Karen Kuntz	No disclosure on file
Jason H. Karlawish, MD	No disclosure on file
Claudia S. Kay, MD	Dr. Kay has nothing to disclose.
Jung-Ju Lee, MD, PhD	No disclosure on file
Dona Locke, PhD	Dr. Locke has nothing to disclose.
Bindu Menon, MD, MBBS, FAAN	Dr. Menon has nothing to disclose.
Pauline Maillard, PhD	Dr. Maillard has nothing to disclose.
Scott Patten, PhD	Dr. Patten has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Canadian Psychiatric Association. Dr. Patten has received publishing royalties from a publication relating to health care.
Fabio Pellegrini	Fabio Pellegrini has received personal compensation for serving as an employee of Biogen. Fabio Pellegrini has received stock or an ownership interest from Biogen.
Mariann Polgar-Turcsanyi	No disclosure on file
Patricia M. Riccio, MD	No disclosure on file
Renee Martin	No disclosure on file
Andrea L. Rosso, MPH	No disclosure on file
Rodolfo Savica, MD, PhD, FAAN	The institution of Dr. Savica has received research support from ACADIA Pharmaceuticals, Inc.
Lonni Schultz, PhD	Dr. Schultz has nothing to disclose.
Jennifer Schymick	No disclosure on file
Alexander Sherman	The institution of Mr. Sherman has received research support from The ALS Association. The institution of Mr. Sherman has received research support from NIH. The institution of Mr. Sherman has received research support from FDA. The institution of Mr. Sherman has received research support from Biogen. The institution of Mr. Sherman has received research support from Amylyx Pharmaceuticals. The institution of Mr. Sherman has received research support from Mitsubishi-Tanabe Pharma America. Mr. Sherman has a non-compensated relationship as a Member, Board of Directors with ALD Connect that is relevant to AAN interests or activities.
Masayoshi Tada, MD, PhD	No disclosure on file
Umit H. Ulas, MD	No disclosure on file
Eric M. McDade, DO	Dr. McDade has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. McDade has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. McDade has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alector. Dr. McDade has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alzamend. Dr. McDade has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alnylam. Dr. McDade has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ionis. Dr. McDade has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche-Genentech. The institution of Dr. McDade has received research support from NIA. The institution of Dr. McDade has received research support from Eli Lilly. The institution of Dr. McDade has received research support from Hoffman-La Roche. The institution of Dr. McDade has received research support from Eisai. The institution of Dr. McDade has received research support from Eisai. Dr. McDade has received intellectual property interests from a discovery or technology relating to health care. Dr. McDade has received personal compensation in the range of $500-$4,999 for serving as a Advisory Board Member with Fondation Alzheimer.
Junger Tang, MD	No disclosure on file
Veronica VanderHorst, MD, PhD	No disclosure on file
Liqun Zhang, MD	No disclosure on file
Jacquelyn L. Bainbridge, MD	The institution of Dr. Bainbridge has received research support from CDPHE. The institution of Dr. Bainbridge has received research support from CDPHE.
Kamakshi Lakshminarayan, MD, PhD	Dr. Lakshminarayan has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ABBOTT Labs. The institution of Dr. Lakshminarayan has received research support from NIH.
Jan H. Veldink, MD, PhD	The institution of Dr. Veldink has received research support from Biogen.
Paul T. Twydell, DO, FAAN	Dr. Twydell has received publishing royalties from a publication relating to health care.
Jeffrey W. Britton, MD, FAAN	Dr. Britton has received personal compensation in the range of $0-$499 for serving as a Online course with American Clinical Neurophysiology Society.
Mariska Kooijmans-Coutinho, MD, PhD	No disclosure on file
David E. Friedman, MD	No disclosure on file
Mahlon R. DeLong, MD	No disclosure on file
Richard J. Nowak, MD	Dr. Nowak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion . Dr. Nowak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for argenx. Dr. Nowak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Nowak has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Immunovant . Dr. Nowak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cabaletta Bio . Dr. Nowak has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amgen. Dr. Nowak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cour Pharma. Dr. Nowak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Nowak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janseen . The institution of Dr. Nowak has received research support from UCB. The institution of Dr. Nowak has received research support from Alexion . The institution of Dr. Nowak has received research support from Janseen. The institution of Dr. Nowak has received research support from Immunovant . The institution of Dr. Nowak has received research support from argenx. The institution of Dr. Nowak has received research support from Amgen. Dr. Nowak has a non-compensated relationship as a Member of the Board of Directors with Myasthenia Gravis Foundation of America (MGFA) that is relevant to AAN interests or activities.
Chin-Sang Chung, MD, PhD	No disclosure on file
Gyeong-Moon Kim, MD	No disclosure on file
Nathan S. Sumner, MD	No disclosure on file
Fredric K. Cantor, MD, FAAN	No disclosure on file
Mazen M. Dimachkie, MD, FAAN	Dr. Dimachkie has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Dimachkie has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Octapharma. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ArgenX. Dr. Dimachkie has received personal compensation in the range of $0-$499 for serving as a Consultant for Catalyst. Dr. Dimachkie has received personal compensation in the range of $0-$499 for serving as a Consultant for Takeda. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medlink. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CSL Behring. Dr. Dimachkie has received personal compensation in the range of $0-$499 for serving as a Consultant for Astellas. Dr. Dimachkie has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Janssen. Dr. Dimachkie has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Dianthus. Dr. Dimachkie has received personal compensation in the range of $0-$499 for serving as a Consultant for TACT / Treat NMD. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cabaletta Bio. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Clinical Neurological Society of America, Inc . Dr. Dimachkie has received personal compensation in the range of $0-$499 for serving as a Consultant for Ig Society, Inc. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abcuro. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amicus. Dr. Dimachkie has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Horizon/Immunovant. Dr. Dimachkie has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMD Serono. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ipsen. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Nuvig. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ��ɫ�� (AAN). Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for American Association of Neuromuscular and Electrodiagnostic Medicine (AANEM). Dr. Dimachkie has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Annexon Biosciences. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AstraZeneca. Dr. Dimachkie has received personal compensation in the range of $0-$499 for serving as a Consultant for Candid Therapeutics. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Creyon Bio, Inc.. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Nuvig Therapeutics. Dr. Dimachkie has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB Biopharma. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vertex Pharmaceuticals. Dr. Dimachkie has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Fortrea. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kriya Therapeutics. The institution of Dr. Dimachkie has received research support from NIH. The institution of Dr. Dimachkie has received research support from The Myositis Association. The institution of Dr. Dimachkie has received research support from Biosensics. Dr. Dimachkie has received intellectual property interests from a discovery or technology relating to health care. Dr. Dimachkie has received intellectual property interests from a discovery or technology relating to health care. Dr. Dimachkie has received intellectual property interests from a discovery or technology relating to health care. Dr. Dimachkie has received publishing royalties from a publication relating to health care. Dr. Dimachkie has received publishing royalties from a publication relating to health care.
Dennis Meletiche	No disclosure on file
Roger L. Weir, MD, FAAN	Dr. Weir has nothing to disclose.
Esteban Cheng-Ching, MD	Dr. Cheng-Ching has received publishing royalties from a publication relating to health care.
Petra Schwingenschuh, MD	Dr. Schwingenschuh has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Dr. Schwingenschuh has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bial. Dr. Schwingenschuh has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merz. Dr. Schwingenschuh has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Stada. Dr. Schwingenschuh has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie.
Douglas M. Franz, MD	No disclosure on file
Aarti Sarwal, MD, FAAN	Dr. Sarwal has received personal compensation in the range of $0-$499 for serving as a Consultant for Stimdia, Inc. Dr. Sarwal has received personal compensation in the range of $0-$499 for serving as a Consultant for Sheinkei. Dr. Sarwal has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Society of Critical Care Medicine . Dr. Sarwal has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Society of Neuroimaging . The institution of Dr. Sarwal has received research support from Butterfly, Inc. The institution of Dr. Sarwal has received research support from Bard. The institution of Dr. Sarwal has received research support from Biogen. The institution of Dr. Sarwal has received research support from Novartis. The institution of Dr. Sarwal has received research support from CVR Global. The institution of Dr. Sarwal has received research support from NIH/NIA R01 AG066910-01 . The institution of Dr. Sarwal has received research support from Image Monitoring. Dr. Sarwal has received personal compensation in the range of $500-$4,999 for serving as a Speaker/Faculty, CME courses with Society of Critical Care Medicine . Dr. Sarwal has received personal compensation in the range of $500-$4,999 for serving as a Speaker at annual congress with Intensive Care Society. Dr. Sarwal has received personal compensation in the range of $500-$4,999 for serving as a Speaker at annual congress with Indian Society of Critical Care. Dr. Sarwal has received personal compensation in the range of $500-$4,999 for serving as a speaker/Faculty for Annual meeting, travel compensation with European Society of Intensive Care Medicine. Dr. Sarwal has received personal compensation in the range of $500-$4,999 for serving as a Speaker with ISICEM. Dr. Sarwal has a non-compensated relationship as a Social Media Editor with Neurocritical Care that is relevant to AAN interests or activities. Dr. Sarwal has a non-compensated relationship as a Secretary with American Society of Neuroimaging that is relevant to AAN interests or activities. Dr. Sarwal has a non-compensated relationship as a President with Association of Indian Neurologists in America that is relevant to AAN interests or activities. Dr. Sarwal has a non-compensated relationship as a Member, Board of Directors with Neurocritical Care Society that is relevant to AAN interests or activities. Dr. Sarwal has a non-compensated relationship as a Section Chair, Neurosciences Section with Society of Critical Care Medicine that is relevant to AAN interests or activities.
Andrea N. Leep Hunderfund, MD	The institution of Dr. Leep Hunderfund has received research support from American Medical Association. The institution of Dr. Leep Hunderfund has received research support from Kern National Network for Caring and Character in Medicine. Dr. Leep Hunderfund has received intellectual property interests from a discovery or technology relating to health care.
David S. Tabby, DO, FAAN	No disclosure on file
Alexander Y. Lau, MD	Dr. Lau has nothing to disclose.
Anne Y. Chan, MD	No disclosure on file
Ya-Ping Yang	No disclosure on file
Chunfeng Liu	No disclosure on file
Luis Fernandez	No disclosure on file
Juan R. Sanchez-Ramos, MD, PhD	No disclosure on file
Marian L. Evatt, MD, FAAN	No disclosure on file
Kwang H. Lee, MD	No disclosure on file
Bruno Lenne, PhD	No disclosure on file
Edo Bottacchi	No disclosure on file
Abdul Malik, MD, FAAN	No disclosure on file
David S. Lynch, MBBS, PhD	Dr. Lynch has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Vigil Neuroscience. Dr. Lynch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. The institution of Dr. Lynch has received research support from Ionis.
Pietro Annovazzi	No disclosure on file
Lana Chahine, MD, FAAN	Dr. Chahine has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gray Matters Technology. The institution of Dr. Chahine has received research support from UPMC. The institution of Dr. Chahine has received research support from MJFF. The institution of Dr. Chahine has received research support from Denali/Biogen. Dr. Chahine has received publishing royalties from a publication relating to health care.
Anthony L. Ritaccio, MD, FAAN	The institution of Dr. Ritaccio has received research support from NIH. Dr. Ritaccio has received intellectual property interests from a discovery or technology relating to health care.
William Birmingham	No disclosure on file
Kan Ding, MD	The institution of Dr. Ding has received research support from National Institute of Aging. The institution of Dr. Ding has received research support from NINDS.
Nicole M. Gatto	No disclosure on file
Bijal M. Mehta, MD	Dr. Mehta has nothing to disclose.
Vladimiro Sinay, MD	No disclosure on file
Galeno Rojas, MD	No disclosure on file
Jun Tsugawa, MD	No disclosure on file
Kyung-Cheon Chung, MD	No disclosure on file
David Bradley, MD	Dr. Bradley has nothing to disclose.
Fang Fang	No disclosure on file
Jung Hwa Kim	No disclosure on file
Tae B. Ahn, MD	No disclosure on file
Elizabeth Potter, DO, PhD	No disclosure on file
Richard G. Brown, PhD	No disclosure on file
Juan Ignacio Rojas, MD	Dr. Rojas has nothing to disclose.
Geraldine Hipp	No disclosure on file
Michal Szulc	No disclosure on file
Camila Pupe, MD	Dr. Pupe has nothing to disclose.
Sarosh R. Irani, MD, PhD, FRCP, FEAN	Dr. Irani has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for AZ, Roche, Cerebral therapeutics, Biogen, Amgen, Argenex, Clarivate, IQVIA, BioHaven therapeutics.. Dr. Irani has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Brain. Dr. Irani has received intellectual property interests from a discovery or technology relating to health care. Dr. Irani has received intellectual property interests from a discovery or technology relating to health care.
Bagar A. Husaini	No disclosure on file
Neil Manus	No disclosure on file
Ugo Paolucci, MD	No disclosure on file
Martin Goldstein, MD	No disclosure on file
Kaiz S. Asif, MD	Dr. Asif has nothing to disclose.
Patrick Waters, PhD	Dr. Waters has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Waters has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB. Dr. Waters has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UBC. The institution of Dr. Waters has received research support from Guthy-Jackson Charitable Foundation. Dr. Waters has received intellectual property interests from a discovery or technology relating to health care.
Bryan Kies, MD	No disclosure on file
Jason J. Sico, MD, FAAN	Dr. Sico has nothing to disclose.
Gregory S. Aaen, MD	Dr. Aaen has nothing to disclose.
Jeremiah Aakre, MPH	Mr. Aakre has nothing to disclose.
Brij M. Ahluwalia-Singh, MD, FAAN	No disclosure on file
Amir M. Arain, MD, FAAN	Dr. Arain has nothing to disclose.
Peggy Auinger	Ms. Auinger has nothing to disclose.
Jeffery Balzer	No disclosure on file
Dae-Il Chang, MD	No disclosure on file
Stanley L. Cohan, MD, PhD, FAAN	Dr. Cohan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Cohan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for AbbVie. Dr. Cohan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Cohan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche Genentech. Dr. Cohan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bristol Myers Squibb (Celgene). Dr. Cohan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Icometrix. Dr. Cohan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. Dr. Cohan has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Cohan has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for sanofi genzyme. Dr. Cohan has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Novartis. Dr. Cohan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Roche Genentech. Dr. Cohan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Bristol Myers Squibb. Dr. Cohan has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Serono. Dr. Cohan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Icometrix.
Donald Crammond	No disclosure on file
Emanuele D'Amico	Emanuele D'Amico has nothing to disclose.
Dacia Dalla Libera, MD	No disclosure on file
Julien Dumurgier	No disclosure on file
Bruno E. Vidal, MD	No disclosure on file
Maria C. Fernandez, MD	Dr. Fernandez has nothing to disclose.
Madeline C. Fields, MD	Dr. Fields has nothing to disclose.
Aisling Carr, MD	No disclosure on file
Giovanni B. Frisoni, MD	No disclosure on file
Weiyi Gao, MD	Dr. Gao has nothing to disclose.
Rohit Kumar Garg, MD, MBBS	No disclosure on file
Oscar S. Gershanik, MD	No disclosure on file
Susanne Grafe, MD	No disclosure on file
Jonathan Graff-Radford, MD, FAAN	Dr. Graff-Radford has received personal compensation for serving as an employee of Mayo Clinic. Dr. Graff-Radford has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NINDS/NIH. Dr. Graff-Radford has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for JAMA Neurology. Dr. Graff-Radford has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Open evidence . The institution of Dr. Graff-Radford has received research support from NIH. The institution of Dr. Graff-Radford has received research support from Eisai. The institution of Dr. Graff-Radford has received research support from Cognition therapeutics. Dr. Graff-Radford has received personal compensation in the range of $5,000-$9,999 for serving as a Faculty Member with IMPACT AD .
Padma S. Gunaratne, MD, FAAN	No disclosure on file
Miguel D. Habeych, MD, MPH	No disclosure on file
Bahareh Hassanzadeh, MD	Dr. Hassanzadeh has nothing to disclose.
William J. Hicks II, MD	Dr. Hicks has nothing to disclose.
Claire Hinnell, MD	No disclosure on file
Jia Huang, MD	No disclosure on file
Siobhan Hutchinson, MD	Dr. Hutchinson has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Hutchinson has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Teva. Dr. Hutchinson has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Teva.
Simon Israeli-Korn, MD	No disclosure on file
Gerardo Iuliano, PhD	Dr. Iuliano has nothing to disclose.
Eun Hye Jeong, MD	No disclosure on file
Junaid Kalia, MD	No disclosure on file
Chafic Y. Karam, MD	Dr. Karam has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alnylam. Dr. Karam has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. Dr. Karam has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Argenx. Dr. Karam has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Annexon. Dr. Karam has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Nuvig. Dr. Karam has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Applied therapeutics. Dr. Karam has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Karam has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Astra Zeneca. Dr. Karam has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Intellia. Dr. Karam has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Takeda. Dr. Karam has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Vertex.
Marianne Kearney	No disclosure on file
Sucjoo Kim, MD	No disclosure on file
Stephen Krieger, MD, FAAN	Dr. Krieger has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Krieger has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. Dr. Krieger has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Krieger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Krieger has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for TG Therapeutics. Dr. Krieger has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Krieger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cycle. The institution of Dr. Krieger has received research support from Novartis. The institution of Dr. Krieger has received research support from Bristol Myers Squibb. The institution of Dr. Krieger has received research support from Biogen. The institution of Dr. Krieger has received research support from Sanofi.
Matthias Kurth, MD, PhD	No disclosure on file
Mohankumar Kurukumbi, MD	Dr. Kurukumbi has nothing to disclose.
Jeffrey S. Kutcher, MD, FAAN	Dr. Kutcher has nothing to disclose.
Lydia C. Kwee, PhD	No disclosure on file
Amy Lee, MD	No disclosure on file
Hyang Woon Lee	No disclosure on file
Paul Eugene P. Lleva, MD, FAAN	Dr. Lleva has nothing to disclose.
Daniel J. MacGowan, MD, FAAN	No disclosure on file
Rohit A. Marawar, MD, FAAN	Dr. Marawar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jazz Pharmaceuticals. Dr. Marawar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SK Pharma. Dr. Marawar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Xenon. Dr. Marawar has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Neurelis.
Stephen J. Marks, MD	No disclosure on file
Letizia Mazzini	No disclosure on file
Jane McChesney	No disclosure on file
Luciana Melamud	No disclosure on file
Lisa M. Misell	No disclosure on file
Umrao R. Monani, PhD	No disclosure on file
Carlos T. Moraes, MD	No disclosure on file
Fernando L. Pagan, MD, FAAN	Dr. Pagan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Acorda. Dr. Pagan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Adamas. Dr. Pagan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amneal. Dr. Pagan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merz. Dr. Pagan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Kyowa Kirin. Dr. Pagan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sunovion. Dr. Pagan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Teva. Dr. Pagan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for US World Meds. Dr. Pagan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Supernus. Dr. Pagan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Dr. Pagan has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Acorda. Dr. Pagan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Adamas. Dr. Pagan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amneal. Dr. Pagan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Sunovion. Dr. Pagan has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Teva. Dr. Pagan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Neurocrine. Dr. Pagan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Sunovion. Dr. Pagan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Supernus. Dr. Pagan has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Journal of Clinical Parkinsonism and related Disorders. Dr. Pagan has stock in Keiferx. The institution of Dr. Pagan has received research support from US World Meds. The institution of Dr. Pagan has received research support from Novartis.
Ji-Young Park, MD	No disclosure on file
Maria Esmeralda Quartuccio	No disclosure on file
Pawan V. Rawal, MD	No disclosure on file
Sharon Reinhard	No disclosure on file
Dalia Rotstein, MD	Dr. Rotstein has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. The institution of Dr. Rotstein has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Rotstein has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Rotstein has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen/Horizon . Dr. Rotstein has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion . Dr. Rotstein has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Rotstein has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi Aventis. Dr. Rotstein has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis . Dr. Rotstein has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Rotstein has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Rotstein has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Alexion . Dr. Rotstein has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Rotstein has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Amgen. The institution of Dr. Rotstein has received research support from MS Canada. The institution of Dr. Rotstein has received research support from National MS Society. Dr. Rotstein has received research support from Li Ka Shing Knowledge Institute. The institution of Dr. Rotstein has received research support from University of Toronto Division of Neurology. The institution of Dr. Rotstein has received research support from Canada's Drug Agency. The institution of Dr. Rotstein has received research support from Amgen. The institution of Dr. Rotstein has received research support from Alexion. The institution of Dr. Rotstein has received research support from Guthy Jackson Foundation .
Silke Schmidt, PhD	No disclosure on file
Robert Schmouder	No disclosure on file
Christopher Schwarz	The institution of Christopher Schwarz has received research support from NIH.
Pradumna Singh, MD	No disclosure on file
Brij M. Singh Ahluwalia	No disclosure on file
Christopher L. Songster	No disclosure on file
Cynthia M. Stonnington, MD	Dr. Stonnington has nothing to disclose.
Yuhei Takado, MD	Dr. Takado has nothing to disclose.
Nauman Tariq, MD	Dr. Tariq has received personal compensation for serving as an employee of NC neurological society .
Parthasarathy Thirumala, MD, FAAN	The institution of Dr. Thirumala has received research support from University of Pittsburgh.
Vahid Tohidi, MD, PhD	Dr. Tohidi has nothing to disclose.
Latchezar D. Traykov, MD	No disclosure on file
Richard M. Tsai, MD	Dr. Tsai has received personal compensation for serving as an employee of Denali Therapeutics. Dr. Tsai has stock in Denali Therapeutics.
Douglas Valenta, MD	No disclosure on file
Okeanis Vaou, MD, FAAN	Dr. Vaou has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for ABBVIE. Dr. Vaou has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Dr. Vaou has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medtronic . Dr. Vaou has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for medtronic. An immediate family member of Dr. Vaou has stock in SAGE. The institution of Dr. Vaou has received research support from Medtronic.
Kevin A. Walker, MD	No disclosure on file
Kurt E. Weaver, PhD	No disclosure on file
Dileep R. Yavagal, MD, FAAN	Dr. Yavagal has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Vascular Dynamics. Dr. Yavagal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Guidepoint. The institution of Dr. Yavagal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GLG. Dr. Yavagal has received personal compensation in the range of $0-$499 for serving as a Consultant for Medtronic. Dr. Yavagal has received personal compensation in the range of $0-$499 for serving as a Consultant for Cerenovus/Johnson & Johnson. Dr. Yavagal has received personal compensation in the range of $0-$499 for serving as a Consultant for Stryker. Dr. Yavagal has received personal compensation in the range of $0-$499 for serving as a Consultant for Poseydon. Dr. Yavagal has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Athersys. Dr. Yavagal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gravity Medical Technology. Dr. Yavagal has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Poseydon. Dr. Yavagal has stock in Poseydon. Dr. Yavagal has stock in Galaxy Therapeutics. Dr. Yavagal has stock in Stentrode. Dr. Yavagal has stock in Gravity Medical. Dr. Yavagal has stock in Gravity Medical Technology. Dr. Yavagal has stock in Athersys. Dr. Yavagal has stock in Rapid Medical . Dr. Yavagal has received intellectual property interests from a discovery or technology relating to health care. Dr. Yavagal has received personal compensation in the range of $5,000-$9,999 for serving as a Medicolegal Expert with Royal Carribean Cruise Line. Dr. Yavagal has received personal compensation in the range of $5,000-$9,999 for serving as a Medicolegal Consultant with Carnival Cruise Line.
Haralabos Zacharatos, MD	Dr. Zacharatos has nothing to disclose.
Laura B. Zahodne	No disclosure on file
Simonetta Galgani, MD	No disclosure on file
Scott D. Newsome, DO, FAAN	Dr. Newsome has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Newsome has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Newsome has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. The institution of Dr. Newsome has received research support from Biogen. The institution of Dr. Newsome has received research support from Genentech/Roche. The institution of Dr. Newsome has received research support from Department of Defense. The institution of Dr. Newsome has received research support from Patient Centered Outcomes Research Institute. The institution of Dr. Newsome has received research support from National MS Society. The institution of Dr. Newsome has received research support from Lundbeck. The institution of Dr. Newsome has received research support from Sanofi. The institution of Dr. Newsome has received research support from Kyverna Therapeutics. Dr. Newsome has received personal compensation in the range of $10,000-$49,999 for serving as a Lead PI for Clinical Trial with Roche.
Horacio Senties Madrid	No disclosure on file
Bethanie N. Morgan, MD	Dr. Morgan has nothing to disclose.
Christopher Grunseich, MD	The institution of Dr. Grunseich has received research support from AnnJi Pharmaceuticals.
Paolo Bellantonio, MD	No disclosure on file
Soojin Park, MD	Dr. Park has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurocritical Care. The institution of Dr. Park has received research support from National Institutes of Health.
Anahita Adeli, MD	No disclosure on file
Sachin Agarwal, MD, MPH	Dr. Agarwal has nothing to disclose.
Rebekah M. Ahmed, MD	Dr. Ahmed has nothing to disclose.
Megan C. Alcauskas, MD	No disclosure on file
Shehzad I. Ali	No disclosure on file
Zaid Al-Qudah, MD	No disclosure on file
Enrica Alteri	No disclosure on file
Tim Anderson	No disclosure on file
Niran Argintaru	No disclosure on file
Tia Aryal, MD	No disclosure on file
Susan M. Asai	No disclosure on file
Charles J. Bae, MD	Dr. Bae has nothing to disclose.
Mark R. Baker, MBBS, PhD, MRCP	No disclosure on file
Mireya E. Balart, MD	No disclosure on file
Jorge A. Barahona, MD	No disclosure on file
Dipannita Basu	No disclosure on file
Mathieu Bataille	No disclosure on file
Leonardo M. Batista, MD	No disclosure on file
Russell M. Bauer, PhD, ABPP	No disclosure on file
Diego J. Bauso, MD	No disclosure on file
Claudia Bavec, MD	No disclosure on file
Shibeshih Belachew, MD	Dr. Belachew has received personal compensation for serving as an employee of Biogen Inc. Dr. Belachew has received stock or an ownership interest from Biogen Inc.
Jeffrey Bigelow, MD	No disclosure on file
Olivier Blin, MD	No disclosure on file
Katherine A. Bohard	No disclosure on file
Kenneth A. Bonnet, PhD	No disclosure on file
Lee Ming M. Boo, PharmD	No disclosure on file
Andrea Boon, MD	Dr. Boon has received personal compensation in the range of $500-$4,999 for serving as a Consultant for HPE cosmetics .
Dreama V. Brar, MD	No disclosure on file
Jennifer Brealy	No disclosure on file
Susan C. Byrne, MD	No disclosure on file
John D. Carroll	No disclosure on file
Sherita Chapman, MD	Dr. Chapman has received personal compensation in the range of $100,000-$499,999 for serving as a Stroke Section Chief with VA Medical Center.
Chiayi Chen, PhD, RN	Dr. Chen has nothing to disclose.
Chun M. Cheung, MRCP	No disclosure on file
Raymond Y. Cheung, PhD	No disclosure on file
Robert Chinnapongse, MD	Dr. Chinnapongse has received personal compensation for serving as an employee of Greenwich Biosciences. Dr. Chinnapongse has stock in Greenwich Biosciences.
Florence Chukwuneke, RN	No disclosure on file
Chandra C. Abbott, PhD	Dr. Abbott has received personal compensation for serving as an employee of Biohaven Pharmaceuticals, Inc. Dr. Abbott has stock in Biohaven Pharmaceuticals, Inc..
Mark R. Cookson	No disclosure on file
Irene Cortese, MD	Dr. Cortese has stock in Keires, AG. Dr. Cortese has stock in Nouscom, AG. Dr. Cortese has stock in PDC*line Pharma.
Lynda M. Cristiano, MD	No disclosure on file
Fernando Dangond, MD, FAAN	Dr. Dangond has received personal compensation in the range of $1,000,000+ for serving as a Head, Global Clinical Development (employee for 12 years) with EMD Serono.
M Z. Darkhabani, MD	No disclosure on file
Ritesh P. Daya	No disclosure on file
Raveen Deol, MD	No disclosure on file
Daniel Desgrandchamps, MD	No disclosure on file
Lisa M. Deuel, MD	Dr. Deuel has nothing to disclose.
L D. DeWitt, MD	Dr. DeWitt has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen.
Lien Diep, MD	Dr. Diep has nothing to disclose.
Jenna Dietz	No disclosure on file
Shelly Miller	No disclosure on file
Cecle Donze, MD	No disclosure on file
Emily Dunn	No disclosure on file
James T. Eckner, MD	An immediate family member of Dr. Eckner has received personal compensation for serving as an employee of Autism Alliance of Michigan. The institution of Dr. Eckner has received research support from NIH. The institution of Dr. Eckner has received research support from Department of Defense. Dr. Eckner has received intellectual property interests from a discovery or technology relating to health care. Dr. Eckner has received personal compensation in the range of $500-$4,999 for serving as a CARE Consortium Publication Committee Member with Indiana University. Dr. Eckner has received personal compensation in the range of $0-$499 for serving as a ��ɫ��al Content Contributor with Move United.
Jennifer Elbaum, MD	No disclosure on file
Tenbit Emiru, MD	No disclosure on file
Alejandro L. Escalaya, MD	Dr. Escalaya has nothing to disclose.
Michelle Fabian, MD, FAAN	Dr. Fabian has nothing to disclose.
Khosro Farhad, MD, FAAN	Dr. Farhad has nothing to disclose.
Beata Ferencz	No disclosure on file
Simona Ferioli, MD	Dr. Ferioli has nothing to disclose.
Jennifer Fine, MD, MBChB	No disclosure on file
Yoram Finkelstein, MD, PhD, FAAN	No disclosure on file
Mary Fitzpatrick, ANP, MPH	No disclosure on file
Jennifer E. Fugate, DO	Dr. Fugate has nothing to disclose.
Julio C. Furlan, MD, PhD, MBA, MSc, FAAN	The institution of Dr. Furlan has received research support from Wings for Life Spinal Cord Research Foundation. The institution of Dr. Furlan has received research support from Craig H Neilsen Foundation. The institution of Dr. Furlan has received research support from Ontario Neurotrauma Foundation. The institution of Dr. Furlan has received research support from Cervical Spine Research Society. The institution of Dr. Furlan has received research support from J P Bickell Foundation. The institution of Dr. Furlan has received research support from Praxis Spinal Cord Institute. The institution of Dr. Furlan has received research support from Cervical Spine Research Society. The institution of Dr. Furlan has received research support from CRANIA. The institution of Dr. Furlan has received research support from Craig H Neilsen Foundation. The institution of Dr. Furlan has received research support from Cervical Spine Research Society. The institution of Dr. Furlan has received research support from Cervical Spine Research Society. The institution of Dr. Furlan has received research support from Tanenbaum Institute for Science in Sport. .
Xiao-Ke Gao, MD	Dr. Gao has nothing to disclose.
Jarred Garfinkle, MD	No disclosure on file
Benjamin P. George, MD	Dr. George has nothing to disclose.
Jose Gien-Lopez, MD	Dr. Gien-Lopez has nothing to disclose.
Dario A. Giobbe, MD	No disclosure on file
Martin Gizzi, MD, PhD, FAAN	No disclosure on file
Eren Gozke, MD	No disclosure on file
Rajesh Gupta, MD	No disclosure on file
Chad Hales, MD, PhD, FAAN	The institution of Dr. Hales has received research support from BrightFocus foundation. The institution of Dr. Hales has received research support from NIH. The institution of Dr. Hales has received research support from State of Georgia. Dr. Hales has a non-compensated relationship as a committee member with AAN that is relevant to AAN interests or activities.
Ameer Hassan, DO	Dr. Hassan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Medtronic. Dr. Hassan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Stryker. Dr. Hassan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Penumbra. Dr. Hassan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Cerenovus. Dr. Hassan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Viz.ai. Dr. Hassan has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genentech. Dr. Hassan has received research support from GE Healthcare.
Diogo C. Haussen, MD	Dr. Haussen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Stryker. Dr. Haussen has received stock or an ownership interest from Viz AI.
Mark Hellman	Mark Hellman has nothing to disclose.
Dennis L. Hill, MD	No disclosure on file
Richard A. Hrachovy, MD	No disclosure on file
Lisa Hunegs	No disclosure on file
Jaechun Hwang, MD	No disclosure on file
Jasmina Ivanova	No disclosure on file
Shahram Izadyar, MD, FAAN	The institution of Dr. Izadyar has received research support from Xenon Pharmaceuticals. An immediate family member of Dr. Izadyar has received publishing royalties from a publication relating to health care.
Laura Jawidzik, MD, FAAN	No disclosure on file
Beomseok Jeon, MD	Dr. Jeon has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. The institution of Dr. Jeon has received research support from peptron. The institution of Dr. Jeon has received research support from zemvax & kael. Dr. Jeon has received personal compensation in the range of $500-$4,999 for serving as a expert panel with Aspen Neuroscience.
Lizabeth Jordan	No disclosure on file
Alexandre Joyeux	No disclosure on file
Chandni P. Kalaria, MD	No disclosure on file
Omar Kass-Hout, MD	No disclosure on file
Tareq Kass-Hout, MD	Dr. Kass-Hout has nothing to disclose.
Kara A. Kennedy, DO	Dr. Kennedy has nothing to disclose.
Raza Khan, MD	An immediate family member of Dr. Khan has received personal compensation for serving as an employee of Pfizer. Dr. Khan has received stock or an ownership interest from Amarin Corporation.
Wolfgang Kohler	No disclosure on file
Daniel Kremens, MD, JD, FAAN	Dr. Kremens has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Supernus. Dr. Kremens has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Neurocrine. Dr. Kremens has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Acadia. Dr. Kremens has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Teva. Dr. Kremens has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Kyowa Kirin. Dr. Kremens has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Acorda. Dr. Kremens has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amneal. Dr. Kremens has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merz. Dr. Kremens has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. Dr. Kremens has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Mitsubishi Tanabe. Dr. Kremens has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Cerevel. Dr. Kremens has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for UCB.
Onica Kuch	No disclosure on file
Hrishikesh Kumar, MD	Dr. Kumar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Zydus .
Samiullah Kundi, MD	No disclosure on file
Selma C. Kunitz, PhD	No disclosure on file
Sonia Lal, MD	No disclosure on file
Helena W. Lau	No disclosure on file
Philippe Lebrun Grandie, MD	No disclosure on file
Laura L. Lehman, MD	The institution of Dr. Lehman has received research support from Children's Tumor Foundation . Dr. Lehman has received personal compensation in the range of $500-$4,999 for serving as a Consultant with Clinical Neurology Society of America.
Maria I. Leite, MD	The institution of Dr. Leite has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB. The institution of Dr. Leite has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Horizon / Amgen. The institution of Dr. Leite has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. The institution of Dr. Leite has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Viela/Horizon/Amgen. The institution of Dr. Leite has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB. The institution of Dr. Leite has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen. The institution of Dr. Leite has received research support from Non-Profit Organization - Myaware. The institution of Dr. Leite has received research support from UCB - Ra Pharma. The institution of Dr. Leite has received research support from Non-Profit Organization - Muscular Dystrophy UK.
Luc Letenneur, MD	No disclosure on file
Richard Li, MD	No disclosure on file
Xuping Li, MD, PhD	No disclosure on file
Tsao-Wei Liang, MD	The institution of Dr. Liang has received research support from Bial R&D Investments S.A.. The institution of Dr. Liang has received research support from Parkinson's Foundation. The institution of Dr. Liang has received research support from AbbVie. The institution of Dr. Liang has received research support from Neuroderm. Dr. Liang has received publishing royalties from a publication relating to health care.
Chen Lin, MD	The institution of Dr. Lin has received research support from VA.
Alan Lipschitz, MD	No disclosure on file
Aaron Lord, MD	Dr. Lord has nothing to disclose.
Codrin I. Lungu, MD, FAAN	Dr. Lungu has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier, inc..
Shoaib E. Malik	No disclosure on file
Saul Martinez-Horta	No disclosure on file
Megan Mason, MD	No disclosure on file
Mark O. McCarron, MD, MRCP	No disclosure on file
Robert A. McGovern, BS	No disclosure on file
Kristi A. McIntosh, MPH	No disclosure on file
Hugh J. McMillan, MD	Dr. McMillan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis Gene Therapies. Dr. McMillan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis Gene Therapies. The institution of Dr. McMillan has received research support from Roche.
Robert B. McQueen, PhD	No disclosure on file
Sebastiao E. Melo-Souza, MD, FAAN	No disclosure on file
Krishe Menezes, MD	No disclosure on file
Bayard D. Miller, MD	No disclosure on file
Kristy L. Miller, MPH	No disclosure on file
Petra Minnasch, MD	No disclosure on file
Nesanet Mitiku, MD	No disclosure on file
Michael Mlynash	No disclosure on file
Frederic Moisan	No disclosure on file
Maxim Mokin, MD, PhD	Dr. Mokin has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Medtronic. Dr. Mokin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cerenovus. Dr. Mokin has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Microvention. Dr. Mokin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cerenovus. Dr. Mokin has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Foley Mansfield.
Phillip C. Mongiovi, MD	Dr. Mongiovi has nothing to disclose.
Mohammad Moussavi, MD	Dr. Moussavi has nothing to disclose.
Bennett H. Myers, MD	No disclosure on file
Carlos S. Navarrete Maldonado, MD	No disclosure on file
Selena Nicholas-Bublick, MD, MHS	No disclosure on file
Rotem Orbach, MD	Dr. Orbach has nothing to disclose.
Susanne Ostrowitzki, MD, PhD	No disclosure on file
Svenja Oynhausen	No disclosure on file
Vitor H. Pacheco, MD	Dr. Pacheco has nothing to disclose.
Miguel A. Padilla Leyva, MD	No disclosure on file
Zahra Pakzad	No disclosure on file
Spozhmy Panezai, MD	Dr. Panezai has nothing to disclose.
Gaurav C. Parikh, MD	No disclosure on file
Swaroop Pawar, MD	Dr. Pawar has nothing to disclose.
Carrie B. Peltz, PhD	No disclosure on file
Mariya I. Petrova	No disclosure on file
Amy L. Phillips, PharmD	Amy L. Phillips, PharmD has received personal compensation for serving as an employee of EMD Serono, Inc.
Michelle A. Prosje, PsyD	No disclosure on file
Jerry N. Pruitt II, MD	No disclosure on file
Alain Ptito, PhD	No disclosure on file
Mushtaq H. Qureshi, MD	No disclosure on file
Jon Rittenberger, MD	No disclosure on file
Carol B. Rockett	No disclosure on file
Vince Tran	No disclosure on file
Victor W. Rosenfeld, MD	No disclosure on file
Francesca Rossi, PhD	No disclosure on file
Stefano Ruggieri	No disclosure on file
Ramandeep Sahni, MD	Dr. Sahni has nothing to disclose.
Mahta Samizadeh	No disclosure on file
Michael Samuel, BMBcH	No disclosure on file
Emmanuel O. Sanya, MD	No disclosure on file
Bilal Saulat, MD	No disclosure on file
Logan D. Schneider, MD	Dr. Schneider has received personal compensation for serving as an employee of Alphabet, Inc. Dr. Schneider has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for Jazz Pharmaceuticals. Dr. Schneider has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Avadel Pharmaceuticals. Dr. Schneider has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Axsome. Dr. Schneider has received intellectual property interests from a discovery or technology relating to health care.
Joe R. Schwab	No disclosure on file
Asfa Y. Shad, MD	No disclosure on file
Chae Won Shin, MD	No disclosure on file
Vladimir Shvarts, MD	Dr. Shvarts has nothing to disclose.
Maheep S. Virdi, MD	No disclosure on file
Christal Sookram	No disclosure on file
Elizabeth Soto Cabrera, MD	No disclosure on file
Christopher N. Sozda	No disclosure on file
Lynn Straatman, MD	No disclosure on file
Tamela Stuchiner	Ms. Stuchiner has nothing to disclose.
Hamid Suhail	No disclosure on file
Shawn M. Sumida, MD	No disclosure on file
Frandy Susatia, MD	No disclosure on file
Yuki Takashima, MD	No disclosure on file
Hiangkiat Tan	No disclosure on file
Mattea L. Tan	No disclosure on file
Marcy L. Tarrants, PhD, MPA	No disclosure on file
James Teo, MD	No disclosure on file
Greg M. Thaera, MD	No disclosure on file
Roger D. Traub, MD	No disclosure on file
Valter Troni, MD	No disclosure on file
Tak H. Tsoi, MD	No disclosure on file
Daniel Varon, MD	No disclosure on file
Karl Vass, MD	No disclosure on file
Matthew Vibbert, MD	Dr. Vibbert has nothing to disclose.
Jean-Sebastien Vidal	No disclosure on file
Jason Viereck, MD, PhD	Dr. Viereck has nothing to disclose.
Raissa Villanueva, MD, FAAN	Dr. Villanueva has received personal compensation in the range of $500-$4,999 for serving as a speaker honoraria, consulting for CPT with AAN. Dr. Villanueva has received personal compensation in the range of $5,000-$9,999 for serving as a migraine research grant reviewer with American Headache Society. Dr. Villanueva has a non-compensated relationship as a Practice Management Committee CoChair with American Headache Society that is relevant to AAN interests or activities.
George Wan	No disclosure on file
Huijun Wang, MD, PhD	No disclosure on file
Anne P. Wilson	No disclosure on file
Jens Wuerfel, MD	Dr. Wuerfel has received personal compensation for serving as an employee of MIAC AG. The institution of Dr. Wuerfel has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Actelion. The institution of Dr. Wuerfel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. The institution of Dr. Wuerfel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche.
Nicole Everman, MD, FAAN	No disclosure on file
Sze Wai E. Yeung, MD	No disclosure on file
Sara Zangeneh, MD	No disclosure on file
Nazlee Zebardast	No disclosure on file
Lana Zhovtis Ryerson, MD, FAAN	Dr. Zhovtis Ryerson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Zhovtis Ryerson has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi.
Ariane Soldatos, MD, FAAN	Dr. Soldatos has nothing to disclose.
Heather D. Harle, MD	No disclosure on file
Andrew M. Southerland, MD, FAAN	Dr. Southerland has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Plaintiffs and Defense Cases related to Stroke and Vascular Neurology.. The institution of Dr. Southerland has received research support from American Heart Association. The institution of Dr. Southerland has received research support from NIH. The institution of Dr. Southerland has received research support from Abbvie Pharmaceuticals, Inc.. Dr. Southerland has received intellectual property interests from a discovery or technology relating to health care. Dr. Southerland has received intellectual property interests from a discovery or technology relating to health care.
Adam D. Falchook, MD	No disclosure on file
Mateo Calderon-Arnulphi, MD	No disclosure on file
Fahmi M. Al-Senani, MBBS	No disclosure on file
Zakiya J. Wynn, MD	No disclosure on file
Behzad Elahi, MD, FAAN	Dr. Elahi has received intellectual property interests from a discovery or technology relating to health care.
Kevin Felice, DO	No disclosure on file
Kerri S. Remmel, MD, PhD	Dr. Remmel has nothing to disclose.
Robert N. Sawyer, Jr., MD	Dr. Sawyer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medtronic. Dr. Sawyer has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Leven Gouldin and Thompson.
Tony M. McGrath, MD	No disclosure on file
Kari D. Moore, RN, APRN	Ms. Moore has nothing to disclose.
Raja Mehanna, MD	Dr. Mehanna has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Teva. Dr. Mehanna has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Kyowa Kirin. The institution of Dr. Mehanna has received research support from Cerevel. The institution of Dr. Mehanna has received research support from Neurocrine.
Bob Bucelli, MD, PhD	Dr. Bucelli has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen . Dr. Bucelli has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Bucelli has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Regeneron. Dr. Bucelli has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Hamilton Weber. Dr. Bucelli has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for O'Bryan Brown and Toner. Dr. Bucelli has stock in Neuroquestions.com. An immediate family member of Dr. Bucelli has stock in Neuroquestions.com. The institution of Dr. Bucelli has received research support from Biogen. The institution of Dr. Bucelli has received research support from Ionis.
Adrienne N. Dula, PhD	No disclosure on file
Benoit Marin	No disclosure on file
Rahul Remanan, MBBS	No disclosure on file
Asako Takanohashi, PhD, DVM	Dr. Takanohashi has nothing to disclose.
Anjail Sharrief, MD	The institution of Dr. Sharrief has received research support from NIH. The institution of Dr. Sharrief has received research support from University of Houston . Dr. Sharrief has a non-compensated relationship as a Consultant with Abbott that is relevant to AAN interests or activities.
Deepti Zutshi, MD, FAAN	Dr. Zutshi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Xenon pharmaceuticals. An immediate family member of Dr. Zutshi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boston Scientific. Dr. Zutshi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Aucta Pharmaceuticals. Dr. Zutshi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Aucta.
Jesse B. Mez, MD	The institution of Dr. Mez has received research support from NIH, DOD.
Daniel B. Simmons, MD	No disclosure on file
Marie Y. Davis, MD, PhD	Dr. Davis has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. The institution of Dr. Davis has received research support from NIH NINDS. The institution of Dr. Davis has received research support from University of Washington Institute for Stem Cell and Regenerative Medicine. The institution of Dr. Davis has received research support from VA BLRD. Dr. Davis has received personal compensation in the range of $500-$4,999 for serving as a study section grant reviewer with NIH. Dr. Davis has received personal compensation in the range of $500-$4,999 for serving as a Grant reviewer with Parkinson's Foundation.
Sanjeeva R. Onteddu, MD, FAAN	Dr. Onteddu has nothing to disclose.
Ryna Then, MD, FAAN	Dr. Then has nothing to disclose.
Brandon E. Beaber, MD	No disclosure on file
Maysaa M. Basha, MD, FAAN	Dr. Basha has nothing to disclose.
Lucas Bonamico	No disclosure on file
Matthew Brock, MD	Dr. Brock has received research support from Department of Defense, Defense Health Program, Congressionally Directed Medical Research Programs.
Subhashie Wijemanne, MD	No disclosure on file
Andrew Kayser, MD, PhD, FAAN	Dr. Kayser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boehringer Ingelheim. The institution of Dr. Kayser has received research support from NIH. The institution of Dr. Kayser has received research support from VA RR&D.
Nina L. Martinez, MD	No disclosure on file
Andres Rodriguez-Ruiz, MD	Dr. Rodriguez-Ruiz has received personal compensation in the range of $0-$499 for serving as a Consultant for Atheneum. Dr. Rodriguez-Ruiz has stock in Lourbeth LLC.
Nidhi Gupta, MD	No disclosure on file
Raymond Price, MD, FAAN	Dr. Price has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for Price Lakeside. Dr. Price has received publishing royalties from a publication relating to health care.
Sammy D. Pishanidar, MD	No disclosure on file
Amelia K. Boehme, PhD	Dr. Boehme has nothing to disclose.
Ethan Brandler	No disclosure on file
Ivy Nguyen, MD	Dr. Nguyen has nothing to disclose.
Varun P. Chaubal, MD	Dr. Chaubal has nothing to disclose.
Erik J. Kobylarz, MD, PhD	No disclosure on file
Ricky Lee, MD	No disclosure on file
Christopher P. Robinson, DO	Dr. Robinson has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for law firms.
Samuel Yip, MD, PhD	Dr. Yip has nothing to disclose.
Hardik R. Doshi, MD	Dr. Doshi has nothing to disclose.
Lauren Koffman, DO, MS	Dr. Koffman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Law Firm. Dr. Koffman has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Walters Kluwer.
Michelle Bell, MD	Dr. Bell has nothing to disclose.
Hannah C. McLane, MD, MPH	No disclosure on file
Stacy V. Smith, MD	Dr. Smith has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Teva. Dr. Smith has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for TEVA . Dr. Smith has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Lilly. Dr. Smith has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Abbvie. Dr. Smith has received publishing royalties from a publication relating to health care.
Siddhart K. Mehta, MD	Dr. Mehta has nothing to disclose.
Seref Demirkaya, PhD	No disclosure on file
Sunil Sheth, MD	Dr. Sheth has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Penumbra. Dr. Sheth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cerenovus. Dr. Sheth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Imperative Care.
Mateus M. Simabukuro, MD	Dr. Simabukuro has nothing to disclose.
Alessandro S. Farias, PhD	No disclosure on file
Leah Harburg	No disclosure on file
Bichun Ouyang	Bichum Ouyang has nothing to disclose.
Serdar Tasdemir, MD	No disclosure on file
Srilatha Thadur, MD	No disclosure on file
Scott D. Spritzer, DO	Dr. Spritzer has nothing to disclose.
Manuel S. Yepes, MD	Dr. Yepes has nothing to disclose.
Donn Dexter, MD, FAAN	Dr. Dexter has nothing to disclose.
Adel Alhazzani, MD, FRCPC, FAAN	Dr. Alhazzani has nothing to disclose.
Alicia S. Parker, MD	An immediate family member of Dr. Parker has received personal compensation in the range of $5,000-$9,999 for serving as an officer or member of the Board of Directors for Sanara Med Tech. An immediate family member of Dr. Parker has stock in Sanara Med Tech. An immediate family member of Dr. Parker has stock in Rochal Industries. An immediate family member of Dr. Parker has stock in Rochal Parnters. The institution of Dr. Parker has received research support from Texas Alzheimer's Research and Care Consortium. The institution of an immediate family member of Dr. Parker has received research support from Rochal Industries. An immediate family member of Dr. Parker has received intellectual property interests from a discovery or technology relating to health care.
Nicolaas C. Anderson, DO, FAAN	Dr. Anderson has nothing to disclose.
Amir Adeli, MD	Dr. Adeli has nothing to disclose.
Yoshie Umemura, MD, FAAN	Dr. Umemura has received personal compensation for serving as an employee of Barrow Neurological Institute. Dr. Umemura has received personal compensation for serving as an employee of University of Michigan. Dr. Umemura has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Servier. Dr. Umemura has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Guidepoint. Dr. Umemura has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Qessential. Dr. Umemura has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Servier. Dr. Umemura has received personal compensation in the range of $500-$4,999 for serving as a Honorarium with Curio Science LLC. Dr. Umemura has received personal compensation in the range of $500-$4,999 for serving as a Honorarium with OncLive. Dr. Umemura has received personal compensation in the range of $500-$4,999 for serving as a Honorarium with MJH Life Sciences.
Philip Van Damme	The institution of Dr. Van Damme has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for QurAlis. The institution of Dr. Van Damme has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. The institution of Dr. Van Damme has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for VectorY. The institution of Dr. Van Damme has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for NRG Therapeutics. The institution of Dr. Van Damme has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Van Damme has received research support from CSL Behring.
Hanna Czarkowska, MD	No disclosure on file
Thomas V. Kodankandath, MD, FAAN	Dr. Kodankandath has nothing to disclose.
Yamin Shwe, MD	No disclosure on file
Amy Chan, MD	Dr. Chan has nothing to disclose.
David M. Sletten, MBA	Mr. Sletten has nothing to disclose.
Jay P. Hinkle, MD	No disclosure on file
Francisco J. Varela, MD	Dr. Varela has nothing to disclose.
Alvino Bisecco	Alvino Bisecco has nothing to disclose.
Alyana Samai	No disclosure on file
Daniel T. Lackland, PhD	An immediate family member of Prof. Lackland has received personal compensation for serving as an employee of Sound Pharmacetical. Prof. Lackland has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wiley Publishing. Prof. Lackland has received publishing royalties from a publication relating to health care.
Elizabeth M. Monohan, MD	Dr. Monohan has nothing to disclose.
Erica S. Westphal	The institution of Ms. Westphal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for McKesson Coorporation. The institution of Ms. Westphal has received research support from Dent Neurologic Institute.
Gloria Kim	No disclosure on file
Miriam E. Koch	No disclosure on file
Thanh Nguyen	No disclosure on file
Mersedeh Bahr Hosseini, MD	No disclosure on file
Shibani S. Mukerji, MD, PhD	Dr. Mukerji has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Dynamed. Dr. Mukerji has or had stock in Gilead Science.Dr. Mukerji has or had stock in Ranpack.Dr. Mukerji has or had stock in Snowflake. An immediate family member of Dr. Mukerji has or had stock in Amgen. The institution of Dr. Mukerji has received research support from NIH. The institution of Dr. Mukerji has received research support from Massachusetts General Hospital.
James B. Burns, MD	No disclosure on file
Chirag S. Shukla, MD, FAAN	No disclosure on file
Andrew Grandinetti	No disclosure on file
Jennifer P. Rubin, MD	Dr. Rubin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Passage Bio.
Adam S. Jasne, MD	Dr. Jasne has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis.
Anna M. Fermin, MD	No disclosure on file
Supriya Mahajan, MD	Dr. Mahajan has nothing to disclose.
Michael H. McManus, MD	No disclosure on file
Lia D. Ernst, MD	Dr. Ernst has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Jazz.
A. Blake Buletko, MD	Dr. Buletko has nothing to disclose.
Mohammad M. Qureshi, MD	No disclosure on file
Murat Kurtuncu, MD	Dr. Kurtuncu has nothing to disclose.
Yuan Xing, MD	No disclosure on file
Katherine C. Bonsell, MD	No disclosure on file
William Sugrue, MD	No disclosure on file
Kedar Mahajan, MD, PhD	Dr. Mahajan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Mahajan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech.
Evdokia Eleftheriou, MD	No disclosure on file
Michelle U. Van Noord, MD	No disclosure on file
Fernanda Wajnsztajn, MD	An immediate family member of Dr. Wajnsztajn has received personal compensation for serving as an employee of Alexion Pharmaceuticals.
Gilbert Green, DO	No disclosure on file
Ashish Kulhari, MD	No disclosure on file
Sushrut Jangi, MD	No disclosure on file
Tamara Hoyt	Ms. Hoyt has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono.
Huimahn A. Choi, MD	The institution of Dr. Choi has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Acasti Pharma.
Patrick Kiernan	No disclosure on file
Julian Bailes, MD	No disclosure on file
Jia Zhen Cheng, MD	No disclosure on file
Gersain Trujillo-Alonso, Sr., MD	No disclosure on file
Danielle C. Mendes, Sr., MD	No disclosure on file
Andrea Lazzarotto	Dr. Lazzarotto has nothing to disclose.
Lisa Federle	No disclosure on file
Sonya Bakshi	No disclosure on file
Christopher Lo, DO	No disclosure on file
Lindsay J. Kaplan	No disclosure on file
Tuncay Gunduz, MD	The institution of Dr. Gunduz has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis Pharmaceuticals. Dr. Gunduz has received research support from Turkish Neuroimmunology Society.
Angela Foley	No disclosure on file
Ryan Metzger, PhD	An immediate family member of Dr. Metzger has received personal compensation for serving as an employee of Neurocrine Biosciences. Dr. Metzger has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Interpro Bioscience. An immediate family member of Dr. Metzger has stock in Ascendis. An immediate family member of Dr. Metzger has stock in Neurocrine Biosciences.
Sabahattin Saip	Sabahattin Saip has nothing to disclose.
Tamara Opila	No disclosure on file
Swetha Renati, MD	Dr. Renati has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bayer. Dr. Renati has received personal compensation in the range of $500-$4,999 for serving as a NeuroSAE with ��ɫ�� .
Gabriel A. Marx	No disclosure on file
Juan C. Bulacio, MD	No disclosure on file
Paul T. Kotzbauer, MD, PhD	No disclosure on file
Deborah R. Gold, MD	No disclosure on file
Jose A. Carrillo, MD	No disclosure on file
Leena Kansal, MD	Dr. Kansal has nothing to disclose.
Fletcher L. Hartsell III, MD, MPH	No disclosure on file
Jonathan Perk, MD, PhD, FAAN	Dr. Perk has nothing to disclose.
Sara K. Rostanski, MD	Dr. Rostanski has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Individual law firms.
Christopher J. Deline, MD	No disclosure on file
Katrina M. Pack, MD	No disclosure on file
Meghan Candee, MD	Dr. Candee has nothing to disclose.
Benjamin A. Jones, MD	Dr. Jones has received personal compensation in the range of $10,000-$49,999 for serving as a expert reviewer with Vaccine Injury Compensation Program.
Alina Rich, MPH	No disclosure on file
Jaskiran Brar, MD	No disclosure on file
Leslie E. Perry Grayson, MD	Dr. Perry Grayson has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Jazz Pharmaceuticals . The institution of Dr. Perry Grayson has received research support from Department of Defense .
Serena Thompson, MD, PhD	Dr. Thompson has nothing to disclose.
Aurelia A. Smith, MD	Dr. Smith has nothing to disclose.
Preston Douglas, MD	No disclosure on file
Ali M. Bayan, MD	No disclosure on file
Aurangzeb Memon, MBBS	No disclosure on file
Hussam A. Assiri	No disclosure on file
Samer Riaz, DO	No disclosure on file
Mena Samaan, MD	No disclosure on file
Weijun Jin, MD	Dr. Jin has nothing to disclose.
Jigar P. Mankad, MD	Dr. Mankad has nothing to disclose.
Emily Lane L. Schlitz Fortenberry, MD	Dr. Schlitz Fortenberry has nothing to disclose.
Supreet Kaur, MD	Dr. Kaur has nothing to disclose.
Dhaval P. Desai, MD	Dr. Desai has nothing to disclose.
Aliza B. Ben-Zacharia, PhD, PhD, DNP, ANP, FAAN	Ms. Ben-Zacharia has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Ms. Ben-Zacharia has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Ms. Ben-Zacharia has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Greenwich Biosciences. Ms. Ben-Zacharia has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for TG Theraputics. The institution of Ms. Ben-Zacharia has received research support from Biogen. The institution of Ms. Ben-Zacharia has received research support from Greenwich Biosciences.
Allison King, MD	No disclosure on file
Thomas Finnegan, Jr., PhD	Dr. Finnegan has nothing to disclose.
Stuart Peltz	No disclosure on file
Daniel Korya, MD	No disclosure on file
Joana Parra, MD	No disclosure on file
Michael Alosco, PhD	The institution of Michael Alosco, PhD has received research support from NIH. The institution of Michael Alosco, PhD has received research support from Life Molecular Imaging Inc.
Julia Button	No disclosure on file
Lindsay J. Howard	Ms. Howard has nothing to disclose.
Christina Luther, NP	No disclosure on file
Jenelle Raynowska, MD	Dr. Raynowska has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Intellisphere, LLC .
Rutvij J. Shah, MD, MBBS	No disclosure on file
Samantha Wasserman	No disclosure on file

��ɫ����

��ɫ����

��ɫ��

��ɫ��